Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1050.Time spend outdoors in summer,50222,0.0961685879218739,0.0466387547795004,0.00475662855405307,0.187580547289695,0.0392210652253565
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1060.Time spent outdoors in winter,48073,-0.0997615460679841,0.0514431502339349,-0.200590120526497,0.00106702839052834,0.052484797706675
PLA2G15,Phospholipase A2 group XV,Physical activities,X1070.Time spent watching television (TV),51437,0.34870410743805,0.0479161531923022,0.254788447181137,0.442619767694962,3.51660862286645e-13
PLA2G15,Phospholipase A2 group XV,Physical activities,X1080.Time spent using computer,48166,-0.206333720713424,0.0460636372416985,-0.296618449707153,-0.116048991719695,7.53187180353903e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X1090.Time spent driving,43924,-0.150284654079821,0.0532380221117236,-0.254631177418799,-0.0459381307408428,0.0047657896923789
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1160.Sleep duration,52239,0.0596142725050306,0.041669609274325,-0.0220581616726465,0.141286706682708,0.152546545275447
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35641,-0.00235489452456462,0.0116835880836281,-0.0252547271684757,0.0205449381193465,0.840270389349814
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35641,0.0146605938092794,0.0112231155469673,-0.0073367126627765,0.0366579002813352,0.191502065922631
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35641,0.0102039027385844,0.0122242874379233,-0.0137557006397452,0.0341635061169141,0.403904210045781
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35641,0.00834110413278802,0.0122857361263515,-0.0157389386748609,0.0324211469404369,0.497209201770718
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35641,0.00826326722116772,0.0123146415583121,-0.0158734302331239,0.0323999646754594,0.502237184529497
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35641,0.0049651899368388,0.0323069843883414,-0.0583564994643104,0.068286879337988,0.877860700684829
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35641,0.0261356908409671,0.032745873258438,-0.0380462207455714,0.0903176024275056,0.424820428732765
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35641,0.0231021220518101,0.0211374978579574,-0.0183273737497864,0.0645316178534066,0.274458797336967
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35641,0.0141926212456291,0.0152713895330837,-0.0157393022392149,0.0441245447304732,0.35273725463202
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35641,0.00756414965118818,0.0100183264601545,-0.0120717702107146,0.027200069513091,0.450257806586669
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35641,0.014856099124751,0.015082571649335,-0.0147057413079457,0.0444179395574476,0.324668653324512
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35641,0.00642460203130682,0.00808497034391917,-0.00942193984277477,0.0222711439053884,0.426854986402484
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35641,0.00825441465262924,0.0105749729543148,-0.0124725323378278,0.0289813616430863,0.435089217628448
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35641,0.0102152372617589,0.0150775273001544,-0.0193367162465438,0.0397671907700616,0.498104141968989
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35641,-0.0113200752682809,0.0141703922940105,-0.0390940441645413,0.0164538936279796,0.424404473556369
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35641,0.0152968560245321,0.0221406044108914,-0.0280987286208151,0.0586924406698793,0.489655745895733
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35641,-0.00768034372096753,0.0210081713273005,-0.0488563595224765,0.0334956720805414,0.714684226991855
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35641,-0.011273102699907,0.0109809569968165,-0.0327957784136673,0.0102495730138533,0.304645128271887
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35641,0.00527932863584142,0.010386652513575,-0.0150785102907656,0.0256371675624485,0.611274324096205
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35641,-0.00295541930128741,0.0132285437907939,-0.0288833651312435,0.0229725265286687,0.823221716084998
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120040.Fatigue severity over the past week,35645,0.402371835515527,0.0858547219745247,0.234096580445459,0.570647090585595,2.83404618441932e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120041.Waking unrefreshed severity over the past week,35643,0.260018658826071,0.0856093881123894,0.0922242581257879,0.427813059526354,0.00239687956524952
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120042.Cognitive symptoms severity over the past week,35645,0.107589768347808,0.0910831805842313,-0.0709332655972851,0.286112802292902,0.237556743990249
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120098.Mobility problems today,35649,0.270084209530524,0.0932248060213635,0.0873635897286516,0.452804829332397,0.00377862812979991
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120099.Self-care problems today,35649,0.211441328168029,0.142017742004032,-0.0669134461598731,0.489796102495932,0.136579061475399
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120100.Problems doing usual activities,35649,0.20493722242949,0.0908903636516491,0.0267921096722581,0.383082335186723,0.0241809101018384
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120101.Pain or discomfort today,35649,0.135989674825066,0.085087692236534,-0.0307822019585408,0.302761551608673,0.110040838891068
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120102.Anxiety or depression today,35649,-0.00207921377560072,0.1072137136577,-0.212218092544693,0.208059664993492,0.984528058597111
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120103.Scale to indicate how health is today,35627,-0.0130744348655318,0.00353279399707287,-0.0199987110997946,-0.00615015863126892,0.000216650791556503
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35624,0.210324426587283,0.109508268857007,-0.00431178037245064,0.424960633547017,0.0548230661289305
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35614,0.0069555914437751,0.114056801652531,-0.216595739795186,0.230506922682736,0.951374189319258
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35630,0.134209427810643,0.0862813653895296,-0.0349020483528347,0.303320903974121,0.119879628019517
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35629,0.330272097277734,0.0880253503660188,0.157742410560337,0.502801783995131,0.000176964918793968
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35640,0.311480232044652,0.125873243800628,0.0647686741954218,0.558191789893883,0.0133657869902311
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120109.Feeling bad about self over the last two weeks,35619,-0.0184257333224943,0.123068087610239,-0.259639185038562,0.222787718393573,0.880990362191477
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120110.Trouble concentrating over the last two weeks,35633,0.0176021596247591,0.121791090962895,-0.221108378662515,0.256312697912033,0.88508848190431
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35632,-0.048807254361971,0.169146542447121,-0.380334477558327,0.282719968834386,0.77293496675596
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35613,-0.538379963973448,0.260536371667782,-1.0490312524423,-0.0277286755045953,0.038828002006073
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33483,0.0955610218356438,0.119574996400923,-0.138805971110165,0.329928014781452,0.424234800491938
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50433,0.232379115276851,0.101763334788523,0.0329229790913456,0.431835251462356,0.0224092928213039
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48626,0.0868911101947049,0.0633715157737046,-0.037317060721756,0.211099281111166,0.170347693369444
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1289.Cooked vegetable intake,51789,-0.228413050817997,0.0438555451655239,-0.314369919342424,-0.142456182293571,1.92243990386478e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50967,-0.321895846472086,0.0457755700032685,-0.411615963678492,-0.232175729265679,2.09551133978219e-12
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1309.Fresh fruit intake,51702,-0.162743940868195,0.0452534602110944,-0.251440722881941,-0.0740471588544503,0.000323495895128493
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1319.Dried fruit intake,50508,-0.304951286703882,0.0455433445608606,-0.394216242043169,-0.215686331364596,2.19762622045911e-11
PLA2G15,Phospholipase A2 group XV,Health and medical history,X134.Number of self-reported cancers,52447,0.167814872622231,0.0692204009715641,0.0321428867179659,0.303486858526497,0.0153431496758049
PLA2G15,Phospholipase A2 group XV,Health and medical history,X135.Number of self-reported non-cancer illnesses,52448,0.408002344681577,0.0456796801226964,0.318470171641093,0.497534517722062,4.49459418460783e-19
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X136.Number of operations, self-reported",52448,0.115139529395701,0.0435185970000613,0.0298430792755807,0.200435979515821,0.00815637534214548
PLA2G15,Phospholipase A2 group XV,Health and medical history,X137.Number of treatments or medications taken,52448,0.434536036425675,0.0436245752638353,0.349031868908558,0.520040203942792,2.51928471870629e-23
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1438.Bread intake,51818,-0.000925623593821628,0.00210119517295277,-0.00504396613280905,0.00319271894516579,0.659562982744043
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1458.Cereal intake,51467,-0.174208892193236,0.0428661936291635,-0.258226631706396,-0.0901911526800756,4.84009631809088e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1488.Tea intake,51739,-0.00640509181201834,0.00203721943933235,-0.0103980419131097,-0.00241214171092693,0.00166850961414381
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1498.Coffee intake,50743,-0.0702293327868215,0.0432904339528832,-0.155078583334473,0.0146199177608296,0.104757407781422
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1528.Water intake,50567,-0.0317794784257954,0.0434359780383194,-0.116913995380901,0.0533550385293106,0.464396637759402
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1568.Average weekly red wine intake,45070,-0.253719363100561,0.0501427668556584,-0.351999186137652,-0.155439540063471,4.24073276021784e-07
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45068,-0.194397882078223,0.0515842652682807,-0.295503042004053,-0.0932927221523923,0.000164792776417911
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1588.Average weekly beer plus cider intake,45115,0.249459010928556,0.057144634124949,0.137455528043656,0.361462493813456,1.27692209755407e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1598.Average weekly spirits intake,45051,0.121884964585225,0.0538180524926501,0.0164015816996312,0.227368347470819,0.0235408593555891
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1608.Average weekly fortified wine intake,45102,0.00988817193217699,0.0820105262822849,-0.150852459581101,0.170628803445456,0.904031582586182
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1737.Childhood sunburn occasions,46076,-0.070448735073589,0.0525634593531337,-0.173473115405731,0.032575645258553,0.180178664669882
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1807.Father's age at death,50310,-0.00515966203085215,0.00196936555130871,-0.00901961851141722,-0.00129970555028708,0.00880025935850128
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1845.Mother's age,32609,-0.0198180575915924,0.00903094799842389,-0.0375187156685032,-0.0021173995146816,0.0282694475815451
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1873.Number of full brothers,52025,0.0760297464178568,0.0415051323378499,-0.00532031296432905,0.157379805800043,0.0669919284296376
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1883.Number of full sisters,52033,0.0831664703956799,0.0417166666848971,0.00140180369328151,0.164931137098078,0.0462073344357033
PLA2G15,Phospholipase A2 group XV,Physical measures,X20015.Sitting height,52278,-0.00113777479988188,0.00262778217717585,-0.00628822786714654,0.00401267826738277,0.665033988269917
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20016.Fluid intelligence score,36788,-0.268173357241832,0.0679736468818866,-0.40140170513033,-0.134945009353334,8.04343359774531e-05
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20018.Prospective memory result,37150,0.354920073588789,0.0825236257602303,0.193173767098738,0.516666380078841,1.72192427445191e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36665,0.00167949945265217,0.00356200421790249,-0.00530202881443671,0.00866102771974105,0.637294589099546
PLA2G15,Phospholipase A2 group XV,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36648,0.00753383527019918,0.00359170830633108,0.000494086989790274,0.0145735835506081,0.0359773374697092
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20023.Mean time to correctly identify matches,52141,0.00939091657944082,0.00214055158655804,0.00519543546978707,0.0135863976890946,1.15358311052943e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#1.Illnesses of father_Heart disease,48995,-0.000164517020324056,0.00446596260789073,-0.00891780373178989,0.00858876969114178,0.970614566007486
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48542,-0.008328811375654,0.00948560630173636,-0.0269205997270573,0.0102629769757493,0.379928932262107
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48507,0.00407579683101793,0.0126921855302,-0.0208008868081741,0.02895248047021,0.74811802074759
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#12.Illnesses of father_Severe depression,48516,-0.0128995305206969,0.0121788759315399,-0.0367701273465151,0.0109710663051213,0.289534464970271
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48539,-0.00519430520125429,0.00842567763494625,-0.0217086333657489,0.0113200229632404,0.537581619501846
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#2.Illnesses of father_Stroke,48718,-0.00721244422510287,0.00561242371492891,-0.0182127947063635,0.00378790625615779,0.198777659370422
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48658,0.0127644058721969,0.00685747730007871,-0.000676249635957388,0.0262050613803511,0.0627048807102655
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48558,0.0124152419730722,0.00890760076509144,-0.00504365552650705,0.0298741394726514,0.163399834513877
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48714,0.0213328743379459,0.00606523402653865,0.00944501564593014,0.0332207330299616,0.000437052139361448
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48702,-0.0104721984003339,0.00562951587196639,-0.021506049509388,0.000561652708720195,0.0628679275559216
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#9.Illnesses of father_Diabetes,48580,0.0164762039613185,0.00801394892490072,0.000768864068513057,0.0321835438541239,0.0398015899048549
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50115,0.00375319371111857,0.00484831971743959,-0.00574951293506303,0.0132559003573002,0.438867060414248
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49951,0.0032203215953442,0.00631935864060108,-0.00916562134023392,0.0156062645309223,0.610339754873192
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49862,-0.00249390446510774,0.0140773448224956,-0.0300855003171991,0.0250976913869836,0.859386567085674
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49887,-0.009391485209392,0.00879805115698998,-0.0266356654770923,0.00785269505830836,0.285780851165648
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#2.Illnesses of mother_Stroke,50043,-0.00405493871790481,0.00531715036574882,-0.0144765534347725,0.00636667599896287,0.445701653680609
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49909,0.0166307820948978,0.010170287481356,-0.00330298136855983,0.0365645455583555,0.102015563283897
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49895,-0.000602580310431249,0.00859616813635699,-0.017451069857691,0.0162459092368285,0.944115769341673
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49899,-0.00583910080026502,0.00759947649146269,-0.0207340747235319,0.00905587312300186,0.442284676513224
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49947,0.00608311996538607,0.00850000813410199,-0.0105768959774538,0.022743135908226,0.474209065969455
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50092,-0.0083928833706964,0.00472485288225626,-0.0176535950199187,0.00086782827852588,0.0756935941911855
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49957,0.0241350711461533,0.00723278193127524,0.00995881856085382,0.0383113237314527,0.000848670685203742
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46277,0.000201500917634006,0.00608327102242251,-0.0117217102863141,0.0121247121215821,0.973576268192348
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46103,-0.00753830454396692,0.0211686735507749,-0.0490289047034857,0.0339522956155519,0.721765171138126
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46093,0.0254432016706694,0.0224933311077589,-0.018643727300538,0.0695301306418768,0.258010443209975
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46126,-0.00650384553550065,0.0093200259027841,-0.0247710963049575,0.0117634052339562,0.485289617485565
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46118,-0.00444934913786005,0.0126164103816341,-0.029177513485863,0.0202788152101429,0.724345017106868
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46154,0.0166576902177365,0.0101445075411155,-0.00322554456284985,0.0365409249983228,0.100600192284726
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46117,0.0135591768900239,0.0113129048923455,-0.00861411669897321,0.0357324704790211,0.230716495952936
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46112,0.0187034976303549,0.0114213591162054,-0.00368236623740767,0.0410893614981176,0.101525954985218
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46131,0.016144286367203,0.00933748665919656,-0.00215718748482221,0.0344457602192283,0.0838316889558657
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46145,0.0116710471879455,0.0110738069640547,-0.0100336144616016,0.0333757088374927,0.291928756064865
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46322,-0.00325881747878744,0.00513062992091552,-0.0133148521237819,0.00679721716620698,0.525326632818731
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46214,0.0346639414467455,0.00705070621426949,0.0208445572667773,0.0484833256267137,8.89810194100856e-07
PLA2G15,Phospholipase A2 group XV,Mental health,X20127.Neuroticism score,47459,0.0513625595682708,0.0436969219563206,-0.0342834074661176,0.137008526602659,0.239839095836257
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36788,-0.0977005413666029,0.0686904441326445,-0.232333811866586,0.0369327291333803,0.154971343415339
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20161.Pack years of smoking,37064,0.0307859074814125,0.00358345436691413,0.0237623369222608,0.0378094780405642,1.02754799547569e-17
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,37064,0.0318810666794647,0.00370221015851315,0.024624734768779,0.0391373985901505,8.62846196075628e-18
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20191.Fluid intelligence score,34380,-0.0698715387359632,0.0858070867904875,-0.238053428845319,0.0983103513733922,0.415518407531005
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34381,-0.0996014790470337,0.0876276895055979,-0.271351750478006,0.0721487923839382,0.255739808744533
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20240.Maximum digits remembered correctly,33732,-0.0554770723596565,0.0947185079741167,-0.241125347988925,0.130171203269612,0.558103173205116
PLA2G15,Phospholipase A2 group XV,Physical measures,X20255.Spirometry QC measure,46377,-0.0461040229787169,0.0558277867176461,-0.155526484945303,0.0633184389878695,0.408914417727162
PLA2G15,Phospholipase A2 group XV,Eye measures,X20261.avMSE,34372,-0.00278984869957543,0.00404680225436327,-0.0107215811181274,0.00514188371897657,0.490605082717994
PLA2G15,Phospholipase A2 group XV,Eye measures,X20262.Myopia diagnosis,34372,-0.0690029842212145,0.106832057065314,-0.27839381606923,0.140387847626801,0.518371786243485
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20280.Glucose-lactate,42646,0.0290104601607926,0.00260357414540055,0.0239074548358075,0.0341134654857777,1.03976391249076e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20281.Spectrometer-corrected alanine,42673,0.0324657503433452,0.00266969962521838,0.0272331390779172,0.0376983616087733,7.5573931976331e-34
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36461,-0.029340970859789,0.01663602864069,-0.0619475869955415,0.0032656452759634,0.0778244428482042
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36461,-0.0443480282882409,0.0310874166771485,-0.105279364975452,0.0165833083989701,0.153750062200116
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36462,0.0362913872416255,0.0521735108830071,-0.0659686940890684,0.138551468572319,0.486707692487307
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36462,-0.0185826019645537,0.0152539772584355,-0.0484803973910873,0.0113151934619799,0.223182370959072
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36462,0.0125565926722201,0.0320664823925321,-0.0502937128171429,0.075406898161583,0.69538005927043
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36465,0.00429816855775398,0.0400854867752006,-0.0742693855216392,0.0828657226371471,0.914613396636305
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36465,0.00907132590199994,0.0246199223027356,-0.0391837218113619,0.0573263736153618,0.712544949325313
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36465,0.0128348103841564,0.0296847011814994,-0.0453472039315824,0.0710168246998951,0.66548445635287
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36465,0.000439387638401997,0.0462136616126622,-0.0901393891224159,0.0910181643992199,0.992414293427499
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36465,0.0584706190684311,0.0546542145269832,-0.048651641404456,0.165592879541318,0.284732166478519
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36465,0.0115987686318378,0.0326424674496483,-0.0523804675694729,0.0755780048331486,0.722354510475428
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36465,0.0631137053549195,0.0565485891391655,-0.0477215293578448,0.173948940067684,0.264417539387438
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36465,0.017109098441049,0.0387516846261593,-0.0588442034262233,0.0930624003083213,0.658859900528242
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36464,0.0542761904255398,0.0529133789193104,-0.0494340322563086,0.157986413107388,0.305040965864922
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36464,-0.0106256670433528,0.0205745560452453,-0.0509517968920335,0.0297004628053279,0.605557978703974
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36464,-0.0215912837538266,0.0381327802290597,-0.0963315330027835,0.0531489654951304,0.571266330649124
PLA2G15,Phospholipase A2 group XV,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36466,-0.0405628641226651,0.066964779934662,-0.171813832794603,0.0906881045492725,0.544710107718544
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20600.Liking for adding salt to foods,36292,0.0769562439283259,0.0759397390710157,-0.0718856446508648,0.225798132507517,0.310910563656229
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20601.Liking for aniseed,36292,-0.00649216952212571,0.0760458037875619,-0.155541944945747,0.142557605901496,0.931968197722823
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20602.Liking for apple juice,36292,0.115886913063754,0.0754133843777643,-0.0319233203166643,0.263697146444172,0.124414131934576
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20603.Liking for apples,36292,-0.108590772901928,0.0778220738157186,-0.261122037580736,0.0439404917768808,0.162947281619113
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20604.Liking for asparagus,36292,-0.172153949821098,0.0767157979072118,-0.322516913719233,-0.0217909859229632,0.0248600339753125
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20605.Liking for aubergine,36292,-0.153866950607556,0.0757453169633962,-0.302327771855813,-0.00540612935930002,0.0422544555673378
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20606.Liking for avocados,36292,-0.0833589817664739,0.0765976749598514,-0.233490424687783,0.0667724611548348,0.276512753683508
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20607.Liking for bacon,36292,-0.0476557509470369,0.0765584254766114,-0.197710264881195,0.102398762987121,0.533649212083114
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20608.Liking for baked or steamed fish,36292,-0.186728588200188,0.0769119021233612,-0.337475916361976,-0.0359812600383998,0.0152144263483933
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20609.Liking for bananas,36292,0.051069508009371,0.0787757537754998,-0.103330969390609,0.20546998540935,0.516818606536327
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36292,-0.17427746466791,0.0761186222646269,-0.323469964306578,-0.0250849650292411,0.0220766130883557
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20611.Liking for beef steak,36292,-0.133273459513363,0.0762612081978957,-0.282745427581238,0.0161985085545128,0.0805780377620402
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20612.Liking for beetroot,36292,0.00582971789724225,0.0770700449500714,-0.145227570204898,0.156887005999382,0.939706204534418
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20613.Liking for bell pepper,36292,-0.0598640330138638,0.0753204838543002,-0.207492181368292,0.0877641153405646,0.426761769267554
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20614.Liking for bicycling,36292,-0.210255013907777,0.0750494871681526,-0.357352008757356,-0.0631580190581982,0.00509953908010461
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20615.Liking for biscuits,36292,0.132433431344767,0.0765337356156391,-0.0175726904618859,0.282439553151419,0.0836036238995721
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20616.Liking for bitter foods,36292,-0.0690335880134122,0.0758509751263445,-0.217701499261047,0.079634323234223,0.362789486292342
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20617.Liking for bitter or ale,36292,-0.113813595586893,0.0773845939867765,-0.265487399800975,0.0378602086271891,0.141402409302463
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20618.Liking for black olives,36292,-0.238915715340181,0.0758580619491512,-0.387597516760517,-0.0902339139198446,0.00164224214473821
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20619.Liking for black pepper,36292,0.000289398261673538,0.0762930428877106,-0.149244965798239,0.149823762321586,0.996973541762199
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20620.Liking for blue cheese,36292,-0.128683587790569,0.0758908284242662,-0.277429611502131,0.0200624359209927,0.0899978307625229
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20621.Liking for bolognese sauce,36292,-0.0223146070719405,0.0764127018236952,-0.172083502646383,0.127454288502502,0.770274175545247
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20622.Liking for broad beans,36292,-0.0894308617056709,0.0760923245359162,-0.238571817796067,0.0597100943847248,0.239916537983895
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20623.Liking for broccoli,36292,-0.245485006367827,0.0783367391781914,-0.399025015157082,-0.0919449975785722,0.00173312625890004
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20624.Liking for brown rice,36292,-0.203619549762396,0.0762878806854656,-0.353143795905908,-0.0540953036188832,0.00762293388071228
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20625.Liking for brussel sprouts,36292,-0.0673478537602878,0.0766058884111738,-0.217495395046189,0.0827996875256128,0.37935125661691
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20626.Liking for burgers (meat),36292,-0.00377371200294063,0.0753640063400461,-0.151487164429431,0.14393974042355,0.960065519382047
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20627.Liking for burn of spicy foods,36292,-0.161020279658513,0.0759801866515167,-0.309941445495486,-0.0120991138215406,0.0341048264009535
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20628.Liking for butter on bread,36292,0.161918781338915,0.0766376298678145,0.0117090267979983,0.312128535879831,0.0346540983286955
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20629.Liking for butternut squash,36292,-0.228579275003715,0.0758381566503115,-0.377222062038326,-0.0799364879691045,0.00258705082914162
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20630.Liking for cabbage,36292,0.0127104565150404,0.0767311586770071,-0.137682614491894,0.163103527521974,0.868437734709136
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20631.Liking for cake,36292,0.0471762971196023,0.0767332054574544,-0.103220785577008,0.197573379816213,0.53870032412092
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20632.Liking for cake icing,36292,0.178644788962967,0.0754413759597203,0.0307796920819148,0.326509885844018,0.0179114651416011
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20633.Liking for capers,36292,-0.18731232822107,0.0750507762384875,-0.334411849648506,-0.0402128067936347,0.0125896082889971
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20634.Liking for cauliflower,36292,0.0349268873078838,0.0772074199429924,-0.116399655780381,0.186253430396149,0.651011010307618
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20635.Liking for cereal or granola bar,36292,-0.104083285453228,0.0756355303144791,-0.252328924869607,0.0441623539631513,0.168829101349774
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20636.Liking for cheesecake,36292,-0.0062916439375178,0.0758540970667839,-0.154965674188414,0.142382386313379,0.933898391518115
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20637.Liking for cherries,36292,-0.0583798490519167,0.0812827132598625,-0.217693967041247,0.100934268937414,0.472637894358637
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20638.Liking for chicken,36292,-0.157983317818453,0.0794471416946859,-0.313699715540038,-0.00226692009686902,0.0467910831959974
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20639.Liking for chilli pepper,36292,-0.116153660311888,0.07587912393649,-0.264876743227408,0.0325694226036328,0.125870300555065
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20640.Liking for chips or french fries,36292,0.1312697075226,0.0763262556928301,-0.0183297536353472,0.280869168680547,0.0855033658341539
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20641.Liking for cigarette smoking,36292,0.0869975008046651,0.129012894337252,-0.165867772096348,0.339862773705678,0.500122362152655
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20642.Liking for cod,36292,-0.0551984099781185,0.0787094388191338,-0.209468910063621,0.0990720901073837,0.483142951419496
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20643.Liking for coffee with sugar,36292,0.0608808548714252,0.0826227112219357,-0.101059659123569,0.222821368866419,0.461235674980998
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20644.Liking for coffee without sugar,36292,-0.0252336433886563,0.0773938144995592,-0.176925519807792,0.12645823303048,0.744402111203172
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20645.Liking for coriander,36292,-0.123424134041653,0.0759119746625179,-0.272211604380188,0.025363336296882,0.104018590551902
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20646.Liking for corn flakes,36292,0.307588137628344,0.0760192186472566,0.158590469079721,0.456585806176967,5.26112311574154e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20647.Liking for cream,36292,0.1375792937017,0.0757283236801345,-0.0108482207113638,0.286006808114764,0.0692978915608973
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20648.Liking for croissant,36292,-0.0424631426558992,0.0762588431008158,-0.191930475133498,0.1070041898217,0.577661780492259
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20649.Liking for cucumber,36292,0.0514198990976927,0.0763973071286311,-0.0983188228744242,0.20115862106981,0.500931663356599
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20650.Liking for curry,36292,-0.00461328602673434,0.0754515615539008,-0.15249834667238,0.143271774618911,0.951247562850802
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20651.Liking for dairy products,36292,0.141214258187306,0.0770075407126876,-0.00972052160956188,0.292149037984174,0.0667297710279665
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20652.Liking for dark chocolate,36292,-0.173760218018145,0.0775280216385904,-0.325715140429782,-0.0218052956065078,0.0250402606787882
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20653.Liking for diet fizzy drinks,36292,0.119870708614267,0.0791017410222873,-0.0351687037894157,0.27491012101795,0.129715945695438
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20654.Liking for dried fruit,36292,-0.125318695359486,0.0769841899176539,-0.276207707598087,0.0255703168791161,0.103601184839981
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20655.Liking for eggs,36292,0.0289480965223054,0.0785312853737546,-0.124973222810254,0.182869415854864,0.712422998733298
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20656.Liking for exercising alone,36292,-0.296852844303873,0.0754141327433366,-0.444664544480813,-0.149041144126933,8.35383944171327e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20657.Liking for exercising with others,36292,-0.17223039276792,0.0754822649816033,-0.320175632131862,-0.0242851534039776,0.0225346027279886
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20658.Liking for extra virgin olive oil,36292,-0.175277459368664,0.0762665078616848,-0.324759814777566,-0.0257951039597613,0.0215780562751564
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20659.Liking for fatty foods,36292,-0.175630886455696,0.0757870485996791,-0.324173501711067,-0.0270882712003255,0.0205088694790464
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20660.Liking for fresh tomatoes,36292,-0.100673114698108,0.0819377329205965,-0.261271071222477,0.059924841826261,0.219242384982155
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20661.Liking for fried chicken,36292,-0.0101689262850662,0.0755702611421215,-0.158286638123624,0.137948785553492,0.892961581024435
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20662.Liking for fried or battered fish,36292,0.0933778642681076,0.0763946981266442,-0.056355744060115,0.24311147259633,0.221631746211092
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20663.Liking for fruit,36292,-0.0329252417580345,0.086617692578534,-0.202695919211961,0.136845435695892,0.703866661680826
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20664.Liking for garlic,36292,-0.130708004450263,0.0762967732164578,-0.28024967995452,0.0188336710539946,0.0867282195659667
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20665.Liking for gherkins,36292,-0.0417903633580883,0.0753013738398685,-0.189381056084231,0.105800329368054,0.578929421066728
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20666.Liking for globe artichoke,36292,-0.194540038196089,0.0757789406601169,-0.343066761889918,-0.0460133145022602,0.0102725402611083
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20667.Liking for goat's cheese,36292,-0.22772412244414,0.0757485717861949,-0.376191323145082,-0.0792569217431978,0.00265360716117654
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20668.Liking for going to a cafe,36292,-0.0564773349891409,0.0767614566746773,-0.206929790071508,0.0939751200932267,0.461906457817983
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20669.Liking for going to the gym,36292,-0.182757038864517,0.075466532660458,-0.330671442879015,-0.0348426348500197,0.0154731730208435
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20670.Liking for going to the pub,36292,-0.123652109587656,0.0758258674422568,-0.272270809774479,0.0249665905991677,0.102990076497631
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20671.Liking for grapefruit,36292,0.0322258250529524,0.075739823124408,-0.116224228270887,0.180675878376792,0.670499279839925
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20672.Liking for green olives,36292,-0.224890621404719,0.0758493888761522,-0.373555423601978,-0.076225819207461,0.0030372773843599
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20673.Liking for haddock,36292,-0.0940284378206042,0.0786923139676026,-0.248265373197105,0.0602084975558968,0.23217108287948
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20674.Liking for ham,36292,-0.00755078503789889,0.0760939046581237,-0.156694838167821,0.141593268092023,0.920958598489204
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20675.Liking for hard cheese,36292,0.0234999053539075,0.077950521235557,-0.129283116267784,0.176282926975599,0.763063383842594
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20676.Liking for herring,36292,-0.170489927612327,0.075198832047736,-0.317879638425889,-0.023100216798764,0.0234086956438692
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20677.Liking for honey,36292,-0.069140979986798,0.0761213121645578,-0.218338751829331,0.0800567918557354,0.363750673410975
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20678.Liking for horseradish or wasabi,36292,-0.137735097160501,0.0753816416533458,-0.285483114801059,0.0100129204800568,0.0677161885184124
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20679.Liking for ice cream,36292,0.0523743300452203,0.0765581871842457,-0.0976797168359012,0.202428376926342,0.493927174038094
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20680.Liking for jam,36292,0.145459734661724,0.0760592300958413,-0.00361635632612509,0.294535825649573,0.0558583189598209
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20681.Liking for kiwi fruit,36292,-0.0407906653497001,0.0768125832910817,-0.19134332860022,0.10976199790082,0.595406694996294
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20682.Liking for lager,36292,0.01066940560043,0.0756832090888882,-0.137669684213791,0.159008495414651,0.887894060967699
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20683.Liking for lamb,36292,-0.220055392105008,0.0769511008714199,-0.370879549812991,-0.0692312343970245,0.00425309442500814
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20684.Liking for lemons,36292,-0.0121368996003176,0.0762548719097373,-0.161596448543403,0.137322649342768,0.87354555190847
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20685.Liking for lentils or beans,36292,-0.114167360303363,0.0765714235612431,-0.2642473504834,0.0359126298766732,0.136008156035648
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20686.Liking for liver,36292,-0.164231038240687,0.0758274879973521,-0.312852914715497,-0.0156091617658767,0.0303558083028385
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20687.Liking for mackerel,36292,-0.270406537217796,0.076191115669121,-0.419741123929274,-0.121071950506319,0.000389118483450947
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20688.Liking for marzipan,36292,0.0957624163759455,0.0756228955917427,-0.0524584589838702,0.243983291735761,0.205441892833548
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20689.Liking for mayonnaise,36292,0.0220293980768065,0.0760337630077328,-0.12699677741835,0.171055573571963,0.772029909335609
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20690.Liking for melon,36292,0.172005276023926,0.0788660324140863,0.0174278524923165,0.326582699555535,0.0292176166585391
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20691.Liking for milk chocolate,36292,0.145853612588578,0.0761270453295374,-0.00335539625731496,0.295062621434472,0.0554149820806393
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20692.Liking for mushrooms,36292,-0.100108489190775,0.0781629698448607,-0.253307910086702,0.0530909317051521,0.200317702291402
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20694.Liking for orange juice,36292,0.186212420489512,0.0761888338409695,0.0368823061612115,0.335542534817812,0.0145459771553849
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20695.Liking for oranges,36292,-0.0518822451278783,0.0780421149401637,-0.204844790410599,0.101080300154843,0.506201300816898
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20696.Liking for pasta,36292,-0.0222512046805848,0.0767655424530008,-0.172711667888466,0.128209258527297,0.771932374002769
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20697.Liking for pears,36292,0.221588439844483,0.0777181645338136,0.0692608373582081,0.373916042330757,0.0043683210094227
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20698.Liking for pizza,36292,-0.0739415848549924,0.0752615794395146,-0.221454280556441,0.0735711108464562,0.325906196161338
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20699.Liking for plain yogurt,36292,-0.15515412701214,0.075967665245993,-0.304050750894286,-0.00625750312999332,0.0411517042171492
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20700.Liking for plums,36292,0.0694912918078079,0.0782048764265048,-0.0837902659881415,0.222772849603757,0.374258974040206
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20701.Liking for pollock,36292,-0.182234106435543,0.0752682579150375,-0.329759891949017,-0.0347083209220699,0.0154973624042183
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20702.Liking for pork chop,36292,-0.109767621656889,0.0760366013468621,-0.258799360296739,0.0392641169829607,0.14889133111158
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20703.Liking for porridge,36292,-0.048252616240232,0.0773426016881173,-0.199844115548942,0.103338883068478,0.532725502930418
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20704.Liking for potato crisps,36292,0.23227100882888,0.075790941025435,0.0837207644190268,0.380821253238732,0.00218760375715035
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20705.Liking for potatoes,36292,0.140761530516175,0.077533426247412,-0.0112039849287522,0.292727045961103,0.0694901336984611
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20706.Liking for prawns,36292,-0.0216871086517492,0.0770049367575318,-0.172616784696511,0.129242567393013,0.778233380210482
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20707.Liking for raw carrots,36292,-0.17953761633094,0.0769254263758999,-0.330311452027703,-0.028763780634176,0.0196278280206343
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20708.Liking for red meat,36292,-0.123944733215492,0.0767259060246237,-0.274327509023755,0.0264380425927702,0.106263792863758
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20709.Liking for red wine,36292,-0.318035857732953,0.0764433176255931,-0.467864760279115,-0.16820695518679,3.21423806279204e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36292,0.224824531324836,0.0784808471697701,0.0710020708720872,0.378646991777586,0.00418623708980832
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20711.Liking for roast chicken,36292,-0.162900678175234,0.0796463571767502,-0.319007538241664,-0.00679381810880336,0.0408621497997115
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20712.Liking for salad dressing,36292,0.0110970660545433,0.0760435226708923,-0.137948238380406,0.160142370489492,0.88398043650353
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20713.Liking for salad leaves,36292,-0.190216035481034,0.0774460527207966,-0.342010298813795,-0.0384217721482724,0.014068825318559
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20714.Liking for salami,36292,-0.162840098039503,0.0755358327183412,-0.310890330167451,-0.0147898659115539,0.0311328823445174
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20715.Liking for salmon,36292,-0.209691995768295,0.0804545648736336,-0.367382942920617,-0.0520010486159735,0.00917069054934221
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20716.Liking for salty foods,36292,0.177491906293495,0.0751669010184222,0.030164780297387,0.324819032289602,0.0182376931115191
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20717.Liking for salty pretzels,36292,0.096766218712627,0.076254611926229,-0.0526928206627818,0.246225258088036,0.204486861163641
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20718.Liking for sardines,36292,-0.138885443919595,0.0762251891352208,-0.288286814624627,0.0105159267854381,0.0684908317424355
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20719.Liking for sausages (meat),36292,-0.00182704205256929,0.0757999308363223,-0.150394906491761,0.146740822386622,0.980770746580246
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20720.Liking for savoury biscuits,36292,0.149151294892654,0.0762562626359276,-0.000310979873764189,0.298613569659072,0.0505135730143316
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36292,-0.213699701013507,0.0753184245617974,-0.36132381315463,-0.0660755888723843,0.00456283807483826
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20722.Liking for skimmed milk,36292,-0.0906696587921489,0.0757213351300502,-0.239083475647047,0.0577441580627495,0.231185925042225
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20723.Liking for smoked fish,36292,-0.128255173014091,0.0767963586729138,-0.278776036013002,0.0222656899848206,0.0949499765751205
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20724.Liking for soft cheese,36292,0.0206591853883446,0.076363108516984,-0.129012507304944,0.170330878081633,0.786753630614761
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20725.Liking for soy sauce,36292,0.011228515230992,0.0758498970171292,-0.137437282922581,0.159894313384565,0.882318568905434
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20726.Liking for soya milk,36292,-0.203252347306333,0.0763846761806776,-0.352966312620461,-0.0535383819922049,0.00781065821648482
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20727.Liking for spicy foods,36292,-0.099152443226183,0.0755276439608216,-0.247186625389393,0.0488817389370273,0.189293952365491
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20728.Liking for spinach,36292,-0.257669611949292,0.0770878867161423,-0.408761869912931,-0.106577353985653,0.00083444224427144
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20729.Liking for spirits,36292,-0.0291296076339906,0.0756134773495167,-0.177332023239043,0.119072807971062,0.700068507351804
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20730.Liking for strawberries,36292,0.075467347728572,0.0828686447891188,-0.0869551960581008,0.237889891515245,0.362491596206451
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36292,0.0737347428789611,0.0775824495626865,-0.0783268582639043,0.225796344021827,0.341938937878162
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20732.Liking for sweet foods,36292,0.155131084899032,0.0755929120189258,0.00696897734193719,0.303293192456126,0.0401877587794056
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20733.Liking for taking the stairs,36292,-0.226935037689647,0.0771254306385001,-0.378100881741107,-0.0757691936381864,0.00326717914797477
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20734.Liking for tea with sugar,36292,-0.0197450111993546,0.0926296841932906,-0.201299192218204,0.161809169819495,0.83120772593985
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20735.Liking for tea without sugar,36292,-0.069727906475245,0.0796092980944639,-0.225762130740394,0.0863063177899044,0.38112689989895
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20736.Liking for tomato ketchup,36292,0.119010045855188,0.0758719453834923,-0.0296989670964567,0.267719058806833,0.116794063912846
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20737.Liking for tinned tuna,36292,-0.0663641878937702,0.0763742906274427,-0.216057797523558,0.0833294217360175,0.384912863133429
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20738.Liking for turnip (white),36292,-0.0543733382196734,0.0756683712779251,-0.202683345924407,0.0939366694850599,0.472427006575214
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20739.Liking for vegetables,36292,-0.0479161777025006,0.0839069970274738,-0.212373891876349,0.116541536471348,0.567975070888165
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20740.Liking for vinegar,36292,0.114227596201971,0.0761129914382443,-0.0349538670169879,0.26340905942093,0.13346128880154
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20741.Liking for watching television,36292,0.092488607416428,0.0765377529368409,-0.0575253883397802,0.242502603172636,0.226931804098309
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20742.Liking for whisky,36292,-0.145328109173505,0.0775804384195224,-0.297385768475769,0.00672955012875934,0.0610740025471219
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20743.Liking for white bread,36292,0.233510366331459,0.0755146263883942,0.0855016986102067,0.381519034052712,0.00199414788484321
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20744.Liking for white rice,36292,0.0466038777494344,0.0754651278081028,-0.101307772754447,0.194515528253316,0.536888457847312
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20745.Liking for white wine,36292,-0.20225706635247,0.0762058640203058,-0.35162055983227,-0.0528935728726711,0.00797006263219337
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36292,-0.151150675215028,0.0772607501652757,-0.302581745538968,0.000280395108912618,0.0504606979865226
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20747.Liking for whole milk,36292,0.0616265309752913,0.0760160479204116,-0.0873649229487153,0.210617984899298,0.417562763531547
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20748.Liking for wholemeal bread,36292,-0.122246406095661,0.0799545363499829,-0.278957297341628,0.0344644851503052,0.126321711682377
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20749.Liking for working up a sweat,36292,-0.228183816508026,0.0762798123217949,-0.377692248658744,-0.0786753843573082,0.00278652262674388
PLA2G15,Phospholipase A2 group XV,Physical measures,X21001.Body mass index (BMI),52341,-0.0493562337844036,0.0092438376563453,-0.0674741555908404,-0.0312383119779668,9.41509274651226e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X21002.Weight,52359,-0.00231491016882444,0.00495669992415546,-0.0120300420201691,0.00740022168252025,0.640485318087286
PLA2G15,Phospholipase A2 group XV,Physical measures,X21021.Pulse wave Arterial Stiffness index,37111,0.0129698762756098,0.00333709798943628,0.00642916421631473,0.0195105883349049,0.000102499009341878
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36103,0.148557119437559,0.0819752930656137,-0.0121144549710442,0.309228693846162,0.0699959082638223
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36121,-0.0616014229125285,0.082984594121002,-0.224251227389692,0.101048381564635,0.457916475314682
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36123,-0.102887586341857,0.0817431387143453,-0.263104138221973,0.0573289655382603,0.208192196938369
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21040.Satisfaction with bowel habits,36075,0.224736316253145,0.0764111690188617,0.0749704249761763,0.374502207530114,0.00328092604448649
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36058,0.260337625579862,0.0820952444619744,0.0994309464343925,0.421244304725332,0.00152497689603323
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21042.Greatest number of times bowels opened per day,36077,0.00365553205703828,0.0811576631619303,-0.155413487740345,0.162724551854422,0.964074857755975
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21043.Least number of times bowels opened per week,36009,-0.0837902162342249,0.0819507814475242,-0.244413747871372,0.0768333154029226,0.306606342968275
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21044.Average number of times bowels opened per day,36041,0.190605748200607,0.0919956924686601,0.0102941909620335,0.370917305439181,0.0383122922082773
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36127,-0.0575965077194833,0.0822988120415283,-0.218902179320879,0.103709163881912,0.484046867296278
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36122,0.0124545089534415,0.082639615208969,-0.149519136856138,0.174428154763021,0.880209898448237
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32834,0.146192053858808,0.145486830578984,-0.138962134076,0.431346241793616,0.315037178104448
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36125,-0.153671061996788,0.0945540875354743,-0.338997073566317,0.031654949572742,0.104161461056945
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36124,-0.0764594949510708,0.124035962840684,-0.319569982118812,0.16665099221667,0.537630975465693
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36122,-0.264430886546204,0.0950717949184715,-0.450771604586408,-0.0780901685059996,0.00542744922796795
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36122,-0.568541471119025,0.232038363371912,-1.02333666332797,-0.113746278910079,0.0143020716144947
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36128,-0.0446527103457544,0.0971828575174485,-0.235131111079953,0.145825690388445,0.645910337312454
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36124,-0.265852360033926,0.0896814698907067,-0.441628041019712,-0.0900766790481412,0.00304299814647026
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35962,0.116218329902548,0.0864476047840769,-0.0532189754742424,0.285655635279339,0.178870985615366
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36118,-0.0579260118658111,0.0828187007538894,-0.220250665343434,0.104398641611812,0.484305878074616
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36124,-0.326082395437113,0.129830176108717,-0.580549540610198,-0.0716152502640284,0.0120408395735238
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36129,-0.320798813806869,0.0835882435147351,-0.48463177109575,-0.156965856517988,0.000125221385902691
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36128,-0.0389994232662144,0.0825058617088831,-0.200710912215625,0.122712065683196,0.636451598158405
PLA2G15,Phospholipase A2 group XV,Working and living environment,X21100.Water hardness (USGS classification),52309,-0.0523524371165948,0.0414022005746544,-0.133500750242918,0.0287958760097278,0.206068963724517
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2139.Age first had sexual intercourse,48479,-0.0124871527588142,0.00225889630561521,-0.0169145895178201,-0.00805971599980843,3.28120563098794e-08
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2149.Lifetime number of sexual partners,47280,-0.0190111751828054,0.0478924132120786,-0.112880305078479,0.0748579547128686,0.691404677765169
PLA2G15,Phospholipase A2 group XV,Physical activities,X22032.IPAQ activity group,47289,-0.36624468365367,0.0473650053313261,-0.459080094103069,-0.273409273204271,1.11059911543273e-14
PLA2G15,Phospholipase A2 group XV,Physical activities,X22033.Summed days activity,47794,-0.0181034989536767,0.00222509381135957,-0.0224646828239414,-0.0137423150834119,4.33822701680785e-16
PLA2G15,Phospholipase A2 group XV,Physical activities,X22034.Summed minutes activity,47289,-0.0187345104343792,0.00220549913233626,-0.0230572887337582,-0.0144117321350001,2.14079991892498e-17
PLA2G15,Phospholipase A2 group XV,Physical activities,X22037.MET minutes per week for walking,46301,-0.0161195547395047,0.00236009825087086,-0.0207453473112116,-0.0114937621677979,8.77500962479719e-12
PLA2G15,Phospholipase A2 group XV,Physical activities,X22038.MET minutes per week for moderate activity,47289,-0.0134419783666927,0.00215566906322848,-0.0176670897306206,-0.00921686700276492,4.5990347931105e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X22039.MET minutes per week for vigorous activity,47289,-0.382672108865019,0.0476085268503838,-0.475984821491772,-0.289359396238267,9.69829596762585e-16
PLA2G15,Phospholipase A2 group XV,Physical activities,X22040.Summed MET minutes per week for all activity,46301,-0.0199119475372831,0.00228867450115824,-0.0243977495595532,-0.0154261455150129,3.60906567107476e-18
PLA2G15,Phospholipase A2 group XV,Eye measures,X2217.Age started wearing glasses or contact lenses,50464,0.00110823480758863,0.00186506888842738,-0.00254730021372904,0.00476376982890629,0.552380773384979
PLA2G15,Phospholipase A2 group XV,Working and living environment,X22501.Year ended full time education,34184,-0.0294280716004963,0.00892139091783224,-0.0469139977994474,-0.0119421454015451,0.000978503538749587
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X22506.Tobacco smoking,34152,-0.282182901816733,0.193322793555277,-0.661095577185076,0.0967297735516103,0.144450685545432
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51123,-0.00120209579069476,0.155892712117859,-0.306751811541698,0.304347619960309,0.993847606993876
PLA2G15,Phospholipase A2 group XV,Physical measures,X23098.Weight,51863,-0.00142800132118059,0.00499597109731233,-0.0112201046719128,0.00836410202955159,0.77501049627875
PLA2G15,Phospholipase A2 group XV,Physical measures,X23099.Body fat percentage,51856,0.0388175631287101,0.00474035526809404,0.0295264668032458,0.0481086594541745,2.77766778714202e-16
PLA2G15,Phospholipase A2 group XV,Physical measures,X23100.Whole body fat mass,51841,0.0338505685070884,0.00467349828644616,0.0246905118656539,0.0430106251485229,4.5260317596662e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X23101.Whole body fat-free mass,51862,-0.0169356620942143,0.00406818890473249,-0.02490931234749,-0.00896201184093867,3.15323754170881e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23102.Whole body water mass,51863,-0.0171603350013518,0.00408125511935707,-0.0251595950352917,-0.00916107496741197,2.62464859904332e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23104.Body mass index (BMI),51863,-0.0486176711223597,0.00924045780141982,-0.0667289684131425,-0.0305063738315768,1.44267967401214e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23105.Basal metabolic rate,51863,-0.0177568778036927,0.00434564275796914,-0.0262743376093122,-0.00923941799807317,4.40129527840862e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23106.Impedance of whole body,51860,0.0320968497399749,0.00331314289081049,0.0256030896739863,0.0385906098059634,3.75344117661891e-22
PLA2G15,Phospholipase A2 group XV,Physical measures,X23107.Impedance of leg (right),51863,0.0206368657152629,0.00267903188561566,0.0153859632194562,0.0258877682110696,1.38226361680262e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X23108.Impedance of leg (left),51863,0.0202326092158197,0.00266299353447859,0.0150131418882417,0.0254520765433977,3.13114142308916e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X23109.Impedance of arm (right),51860,0.0292814891791143,0.00326885861903175,0.022874526285812,0.0356884520724165,3.56452604536114e-19
PLA2G15,Phospholipase A2 group XV,Physical measures,X23110.Impedance of arm (left),51863,0.0299255503063228,0.00328179548625099,0.0234932311532709,0.0363578694593748,8.2225593122544e-20
PLA2G15,Phospholipase A2 group XV,Physical measures,X23111.Leg fat percentage (right),51863,0.0303716082056011,0.0055865065945724,0.0194220552802392,0.041321161130963,5.4867045018828e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23112.Leg fat mass (right),51863,0.0354897487339342,0.00612285124608238,0.0234889602916127,0.0474905371762556,6.87014786522733e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X23113.Leg fat-free mass (right),51862,-0.0121960286151561,0.00414098179154615,-0.0203123529265865,-0.0040797043037256,0.00323071578021144
PLA2G15,Phospholipase A2 group XV,Physical measures,X23114.Leg predicted mass (right),51862,-0.0120288636879458,0.00416710250490807,-0.0201963845975656,-0.00386134277832598,0.00389765369675988
PLA2G15,Phospholipase A2 group XV,Physical measures,X23115.Leg fat percentage (left),51860,0.0308596424484989,0.00587545841835437,0.0193437439485243,0.0423755409484735,1.51571421113355e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23116.Leg fat mass (left),51860,0.0354097809971523,0.00641371260740754,0.0228389042866336,0.0479806577076711,3.40869242324009e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23117.Leg fat-free mass (left),51859,-0.010235903372462,0.00435876093200162,-0.0187790747991852,-0.00169273194573885,0.018865254626459
PLA2G15,Phospholipase A2 group XV,Physical measures,X23118.Leg predicted mass (left),51859,-0.0104586400064902,0.00438632718027277,-0.0190558412798249,-0.00186143873315561,0.0171164285128098
PLA2G15,Phospholipase A2 group XV,Physical measures,X23119.Arm fat percentage (right),51859,0.0293343330171056,0.00535799675195487,0.0188326593832741,0.0398360066509372,4.42479302676892e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23120.Arm fat mass (right),51857,0.0119758055476729,0.00535255610285872,0.00148479558606984,0.022466815509276,0.0252699311043323
PLA2G15,Phospholipase A2 group XV,Physical measures,X23121.Arm fat-free mass (right),51858,-0.019999580249243,0.00415609000669069,-0.0281455166623568,-0.0118536438361292,1.50302734149865e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23122.Arm predicted mass (right),51858,-0.0199754226439678,0.00416547377508861,-0.0281397512431415,-0.0118110940447941,1.63320647458626e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23123.Arm fat percentage (left),51857,0.0352528095851544,0.00548481012478161,0.0245025817405825,0.0460030374297264,1.32429119627022e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23124.Arm fat mass (left),51857,0.0129528631129503,0.0053608049120539,0.00244568548532469,0.023460040740576,0.0156906022309291
PLA2G15,Phospholipase A2 group XV,Physical measures,X23125.Arm fat-free mass (left),51857,-0.0214837581027982,0.00424199462453968,-0.0297980675668959,-0.0131694486387004,4.12593769934639e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23126.Arm predicted mass (left),51855,-0.0215524496654729,0.00424451970764024,-0.0298717082924477,-0.013233191038498,3.85032049352429e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23127.Trunk fat percentage,51854,0.0263464558404971,0.00339241618903068,0.0196973201099969,0.0329955915709972,8.4239454327279e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,X23128.Trunk fat mass,51854,0.0279487951022372,0.00379390060057087,0.0205127499251183,0.0353848402793561,1.80789437544009e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X23129.Trunk fat-free mass,51853,-0.0170603509620719,0.00367089234158198,-0.0242552999515725,-0.00986540197257117,3.37927068131707e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23130.Trunk predicted mass,51850,-0.0171492071030909,0.00368156931633553,-0.0243650829631086,-0.00993333124307329,3.20915737174917e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23400.Total Cholesterol,42679,-0.0128102509896622,0.00262038862373976,-0.0179462126921921,-0.00767428928713225,1.02681277408856e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42679,-0.00683226592891166,0.00254491307876446,-0.01182029556329,-0.00184423629453331,0.00726889935219887
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42679,0.00121546045172951,0.00254326370169106,-0.00376933640358496,0.00620025730704399,0.632719408655664
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23403.VLDL Cholesterol,42679,0.0117065842530381,0.00258487114579658,0.00664023680727684,0.0167729316987994,5.98041862913846e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23404.Clinical LDL Cholesterol,42679,-0.015701381779495,0.00253897994996906,-0.0206777824814344,-0.0107249810775557,6.42489479288073e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23405.LDL Cholesterol,42679,-0.014144522973368,0.00255185520072825,-0.0191461591667954,-0.00914288677994066,3.03192201437489e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23406.HDL Cholesterol,42679,-0.0283519556317842,0.00292068653949642,-0.0340765012491972,-0.0226274100143712,3.31821240544048e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23407.Total Triglycerides,42679,0.0335396316231123,0.00277979286463942,0.028091237608419,0.0389880256378055,2.38577888267828e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23408.Triglycerides in VLDL,42679,0.0283178971124611,0.00277448124318092,0.0228799138758265,0.0337558803490957,2.27264147431826e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23409.Triglycerides in LDL,42679,0.0397944174351313,0.0027491507164712,0.0344060820308477,0.0451827528394149,3.92198624635696e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23410.Triglycerides in HDL,42679,0.0494665775177438,0.00270261403812728,0.0441694540030143,0.0547637010324733,6.11260271653643e-74
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42679,0.00271625026936797,0.00271972973597898,-0.00261442001315083,0.00804692055188677,0.317947951293198
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23412.Phospholipids in VLDL,42679,0.0212135404639725,0.00266332563270964,0.0159934222238616,0.0264336587040834,1.78315627782892e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23413.Phospholipids in LDL,42679,-0.0119459835480729,0.00253790557867651,-0.0169202784822789,-0.00697168861386697,2.53859111874689e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23414.Phospholipids in HDL,42679,-0.00412073002059512,0.00291368786921954,-0.00983155824426542,0.00159009820307518,0.157306869412998
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23415.Total Esterified Cholesterol,42679,-0.0148536182366533,0.0026322294398301,-0.0200127879387203,-0.00969444853458635,1.704966526849e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42679,0.0080057984173372,0.00255553823547476,0.00299694347580667,0.0130146533588677,0.00173562435630877
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42679,-0.0115555366829649,0.0025563837368295,-0.0165660488071507,-0.0065450245587791,6.22874502329218e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42679,-0.0321756203163803,0.00290195795674675,-0.037863457911604,-0.0264877827211567,1.91334551165299e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23419.Total Free Cholesterol,42679,-0.00766367741502405,0.00259282153664916,-0.0127456076268564,-0.00258174720319169,0.00312470966530916
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23420.Free Cholesterol in VLDL,42679,0.0163547330582953,0.00263547880932041,0.0111891945920273,0.0215202715245633,5.60828030523136e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23421.Free Cholesterol in LDL,42679,-0.0207846677989285,0.00255191020423354,-0.0257864117992262,-0.0157829237986308,4.13273062907267e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23422.Free Cholesterol in HDL,42679,-0.0133192734488796,0.00295996316266334,-0.0191208012476997,-0.00751774565005943,6.85829983611593e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42679,0.00448175283889852,0.00261930219491626,-0.000652079463137342,0.00961558514093439,0.087095175712301
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23424.Total Lipids in VLDL,42679,0.0234302792840759,0.002698407688809,0.0181414002140103,0.0287191583541416,4.29316239571981e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23425.Total Lipids in LDL,42679,-0.0106333617376526,0.00255181847790377,-0.015634925954344,-0.00563179752096121,3.10593948204919e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23426.Total Lipids in HDL,42679,-0.0113728458815364,0.00292756254032119,-0.0171108684605659,-0.00563482330250682,0.000102925039044344
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42679,-0.0155330982294426,0.00275881109744799,-0.0209403679804406,-0.0101258284784445,1.83423454359817e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23428.Concentration of VLDL Particles,42679,0.0178340675779668,0.00262869896146542,0.0126818176134946,0.0229863175424391,1.21458285610575e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23429.Concentration of LDL Particles,42679,-0.00826646685727823,0.00253302766213166,-0.0132312010750563,-0.00330173263950018,0.00110329713090688
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23430.Concentration of HDL Particles,42679,-0.0159953286404651,0.00276403777409426,-0.0214128426776898,-0.0105778146032403,7.32720697352958e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42679,0.0161465999984518,0.00283247119130136,0.0105949564635011,0.0216982435334025,1.21934509208131e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23432.Average Diameter for LDL Particles,42679,-0.0309689966210417,0.00268811824450195,-0.0362377083802655,-0.0257002848618179,1.44242972789613e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23433.Average Diameter for HDL Particles,42679,-0.0134722431051927,0.00303341083758694,-0.0194177283468631,-0.0075267578635223,9.01345103121242e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23434.Phosphoglycerides,42667,0.00659982150858585,0.00277149256767181,0.0011676960759491,0.0120319469412226,0.017264342813835
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42667,0.0369463169031908,0.00288542922081795,0.0312908756303877,0.042601758175994,2.55479953784085e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23436.Total Cholines,42667,0.00144084305030373,0.00277489744390534,-0.00399795593975073,0.00687964204035819,0.603600585363119
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23437.Phosphatidylcholines,42667,0.00466164670530126,0.00279611439170443,-0.000818737502439435,0.0101420309130419,0.0955003875860069
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23438.Sphingomyelins,42667,-0.012571492612146,0.00272041118773933,-0.0179034985401151,-0.0072394866841769,3.85114060823614e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23439.Apolipoprotein B,42679,-0.00425796507033397,0.00253230593266903,-0.00922128469836527,0.000705354557697329,0.0926972205024395
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23440.Apolipoprotein A1,42679,-0.0093771399457317,0.00285736363706214,-0.0149775726743735,-0.00377670721708991,0.00103428887350304
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42679,0.000410987004302703,0.00259623615916576,-0.00467763586766218,0.00549960987626759,0.874221922559053
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23442.Total Fatty Acids,42667,0.0162740985752449,0.00269446272302808,0.0109929516381099,0.02155524551238,1.58337505861095e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23443.Degree of Unsaturation,42667,-0.0726272696969999,0.00267149874053409,-0.0778634072284467,-0.0673911321655531,1.72740116812047e-158
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23444.Omega-3 Fatty Acids,42667,-0.0331496996089688,0.00270670691331741,-0.0384548451590709,-0.0278445540588667,2.64499621551141e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23445.Omega-6 Fatty Acids,42667,-0.00964658167943419,0.00265933272343244,-0.0148588738173618,-0.0044342895415066,0.000287297793322098
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42667,-0.0167651365355021,0.00269230700743602,-0.0220420582700767,-0.0114882148009275,4.89409077826123e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42667,0.0297662003120155,0.00275396309324843,0.0243684326492486,0.0351639679747825,4.0534949958241e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23448.Saturated Fatty Acids,42667,0.0299223672027917,0.00268519175956669,0.024659391354041,0.0351853430515424,1.02867666233467e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23449.Linoleic Acid,42667,-0.00576819806836688,0.00260596716673545,-0.0108758937151684,-0.000660502421565393,0.0268827964156066
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23450.Docosahexaenoic Acid,42667,-0.0440941399209517,0.00269309951815146,-0.0493726149765285,-0.0388156648653748,1.12254377011574e-59
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42667,-0.0490820421418132,0.00266036530290396,-0.054296358135505,-0.0438677261481215,4.42559092884272e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42667,-0.0508737972398892,0.00286095654511701,-0.0564812720683186,-0.0452663224114599,6.1149279583392e-70
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42667,-0.069678373149508,0.00279370456923281,-0.0751540341052043,-0.0642027121938117,2.88570929176474e-134
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42667,0.0479596843601558,0.00286751483164125,0.042339355290139,0.0535800134301727,3.63548796509541e-62
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42667,0.0607062514706452,0.00257475202755979,0.055659737496628,0.0657527654446624,1.77550420869454e-120
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42667,-0.037320911115425,0.00276373291169416,-0.0427378276223456,-0.0319039946085045,2.75564311226581e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42667,-0.0530052790270989,0.00264896094751455,-0.0581972424842274,-0.0478133155699703,8.4816354918275e-88
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42667,-0.0605674615872418,0.00285415421330348,-0.0661616038453166,-0.054973319329167,2.47568019563229e-98
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42667,0.0319830081727525,0.00265084008340837,0.0267873616092721,0.0371786547362329,2.39465244292768e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23460.Alanine,42673,0.0271773173865291,0.00262454526350231,0.0220332086700646,0.0323214261029937,4.92688012209762e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23461.Glutamine,42635,-0.0102824975359968,0.00263062001525603,-0.0154385127658986,-0.00512648230609498,9.32210812963081e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23462.Glycine,42663,-0.00223034729826149,0.00280278482252493,-0.00772380555041036,0.00326311095388738,0.426184895318967
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23463.Histidine,42659,-0.00991447638812827,0.00259117537589761,-0.0149931801248876,-0.00483577265136895,0.000130699749184117
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42669,0.00380294838537254,0.0027447327717443,-0.00157672784724629,0.00918262461799137,0.165909079837409
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23465.Isoleucine,42675,0.00359466526630387,0.00267493639924358,-0.00164821007621356,0.00883754060882129,0.1790253191068
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23466.Leucine,42675,0.000687566495428569,0.00270887641322108,-0.00462183127448475,0.00599696426534189,0.799638639493042
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23467.Valine,42669,0.00575421216912672,0.00277180900404523,0.000321466521198078,0.0111869578170554,0.0379149799373617
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23468.Phenylalanine,42671,0.0142830196394297,0.00262419680036198,0.00913959391072021,0.0194264453681392,5.33621599435496e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23469.Tyrosine,42662,0.0214496364323943,0.00266175362079092,0.0162325993356441,0.0266666735291445,8.37310328721873e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23470.Glucose,42652,0.0139699768365575,0.00259156664259712,0.00889050621706717,0.0190494474560479,7.14260532658761e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23471.Lactate,42654,0.0319120789231883,0.00258069225654571,0.0268539221003587,0.0369702357460179,6.20059142557671e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23472.Pyruvate,42639,0.0158632541775605,0.00261955243836746,0.0107289313983602,0.0209975769567607,1.43524722344466e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23473.Citrate,42676,0.0172876181467386,0.0026283733367311,0.0121360064067456,0.0224392298867315,4.96712388640209e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23474.3-Hydroxybutyrate,42456,0.00371605412099792,0.00275325454487912,-0.00168032478696515,0.00911243302896099,0.1771368476734
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23475.Acetate,42667,-0.0156656949598411,0.00258583410502414,-0.0207339298056884,-0.0105974601139938,1.41254742455136e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23476.Acetoacetate,42677,-0.00971093191295183,0.00265783594863239,-0.0149202903722713,-0.00450157345363234,0.000259469903711475
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23477.Acetone,42677,-0.0175429201119911,0.00262986585392377,-0.0226974571856817,-0.0123883830383005,2.64603017868767e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23478.Creatinine,42366,-0.00113462063236678,0.00294849421464949,-0.00691366929307978,0.00464442802834621,0.700381745426559
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23479.Albumin,42676,-0.0102638051765175,0.00262824505565534,-0.015415165485602,-0.00511244486743308,9.46090149516576e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23480.Glycoprotein Acetyls,42679,0.0262933448371222,0.0027780162415457,0.0208484330036927,0.0317382566705518,3.42233616565958e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42679,0.0393914252036074,0.00278808059630287,0.0339267872348538,0.0448560631723611,5.30592650414419e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42679,0.038339272942834,0.00275663176736463,0.0329362746787994,0.0437422712068687,1.1338031673515e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42679,0.0404643243957247,0.00279193676313388,0.0349921283399823,0.0459365204514671,3.02538243845219e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42679,0.0383090408143042,0.00276664916656121,0.0328864084478443,0.0437316731807642,2.63369450603527e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42679,0.0367321283383094,0.00273500530103385,0.0313715179482831,0.0420927387283358,7.34695753911701e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42679,0.0391536055954733,0.00279193486520017,0.033681413259681,0.0446257979312656,2.28353748867568e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42679,0.036382268101823,0.00273300335741987,0.03102558152128,0.0417389546823659,3.5247350370515e-40
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42679,0.031234491663311,0.00278291414776974,0.0257799799336823,0.0366890033929397,4.19988584567203e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42679,0.0298967570880471,0.00277025120241346,0.0244670647313167,0.0353264494447775,4.8388500319911e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42679,0.0306732694904066,0.00276096777777068,0.0252617726459761,0.0360847663348372,1.49837585668062e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42679,0.0230186414648366,0.00270271258938842,0.0177213247896353,0.0283159581400379,1.81144440204534e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42679,0.017236002565111,0.00266263811724514,0.0120172318553105,0.0224547732749115,9.92165747222742e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42679,0.0283318022539345,0.00274240480623268,0.0229566888337185,0.0337069156741505,6.31973822648608e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42679,0.0317279754824789,0.00278538548506165,0.0262686199317581,0.0371873310331998,6.36158700939117e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42679,0.0250533391575551,0.00275414999245962,0.0196552051723343,0.030451473142776,1.06108385633054e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23496.Total Lipids in Large VLDL,42679,0.0216923241064664,0.00274089531833137,0.0163201692825369,0.0270644789303959,2.67919006696101e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23497.Phospholipids in Large VLDL,42679,0.0273643367123104,0.00275027926931366,0.0219737893444557,0.0327548840801652,3.04307699058327e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23498.Cholesterol in Large VLDL,42679,0.0194510633486322,0.00270053094562944,0.0141580226951985,0.0247441040020659,6.21708423194778e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42679,0.014322762571137,0.00265503661689435,0.00911889080202404,0.0195266343402499,6.9850134116743e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42679,0.0238907787045417,0.00274799932432139,0.0185047000288717,0.0292768573802116,3.90327256531274e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23501.Triglycerides in Large VLDL,42679,0.0192303843243288,0.00273932921732521,0.0138612990583714,0.0245994695902863,2.32302937536119e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42679,0.0027602781203041,0.0025888240521174,-0.00231381702184601,0.0078343732624542,0.286339427218882
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42679,0.00638425786587097,0.00261692688428523,0.00125508117267192,0.01151343455907,0.0147162825861656
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42679,0.00288581135256648,0.00257747752307019,-0.00216604459265109,0.00793766729778404,0.262893029335176
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42679,-0.0109280614984941,0.00252887998869104,-0.0158846662763286,-0.00597145672065972,1.56220256739172e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42679,-0.0174704683609501,0.0025341621791915,-0.0224374262321654,-0.0125035104897347,5.66651658442775e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42679,-0.0017235035639603,0.00255891029346268,-0.00673896773914716,0.00329196061122655,0.50062153550431
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42679,0.016666068051198,0.0027165147839981,0.0113416990745617,0.0219904370278343,8.74911981655694e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42679,0.0178745076789514,0.00266962174145218,0.0126420490657051,0.0231069662921977,2.23411646469192e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23510.Total Lipids in Small VLDL,42679,0.0168856997872597,0.00266220610220299,0.0116677758269419,0.0221036237475776,2.32908073569879e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23511.Phospholipids in Small VLDL,42679,0.00573906619241303,0.00260181949874522,0.000639499974872406,0.0108386324099537,0.0274155437702638
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23512.Cholesterol in Small VLDL,42679,0.00672754616945768,0.00257681210436441,0.00167699444490344,0.0117780978940119,0.0090430125054389
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42679,0.0116099894527146,0.00258896889852575,0.00653561041160414,0.0166843684938251,7.37207272066732e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42679,-0.00163269807290657,0.00255694251257532,-0.0066443053975542,0.00337890925174106,0.523136122187942
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23515.Triglycerides in Small VLDL,42679,0.0288612100257773,0.00275795722725981,0.0234556138603481,0.0342668061912065,1.57149221699312e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42679,0.0202654461159168,0.00259601962185353,0.0151772476570839,0.0253536445747497,6.31902031056438e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42679,0.0212472109439706,0.00262064774068133,0.0161107413722352,0.026383680515706,5.60477010819525e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42679,0.0238527463142856,0.00262131194202189,0.0187149749079226,0.0289905177206485,1.03266227493892e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42679,0.00807654817585293,0.00259002843967845,0.00300009243408317,0.0131530039176227,0.0018226551064769
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42679,0.00424117260276805,0.00259330981551961,-0.00084171463565038,0.00932405984118647,0.101982605448357
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42679,0.0166911845717295,0.0026022996944716,0.0115906771705651,0.0217916919728938,1.46467050520545e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42679,0.0416782690113742,0.00274212672109978,0.0363037006380186,0.0470528373847297,9.59496961020763e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23523.Concentration of IDL Particles,42679,-0.00160904337270364,0.00251835778912669,-0.00654502463939196,0.00332693789398468,0.522882156280879
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23524.Total Lipids in IDL,42679,-0.00613093417278413,0.00259132146534705,-0.0112099242448643,-0.00105194410070392,0.017997985445165
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23525.Phospholipids in IDL,42679,-0.00546952176123564,0.00259810627167943,-0.0105618100537273,-0.000377233468743961,0.0352927366564341
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23526.Cholesterol in IDL,42679,-0.0116609097405416,0.00258792359726325,-0.0167332399911776,-0.00658857948990566,6.66497973408551e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42679,-0.0116020313947079,0.00258948202852114,-0.0166774161706093,-0.00652664661880645,7.51004962736217e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23528.Free Cholesterol in IDL,42679,-0.0115698488026067,0.00258247636209061,-0.0166315024723043,-0.00650819513290913,7.52086110402597e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23529.Triglycerides in IDL,42679,0.043205904439375,0.00274068251461685,0.037834166710726,0.0485776421680241,1.7037115450823e-55
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23530.Concentration of Large LDL Particles,42679,-0.0118206518660792,0.00253188399103218,-0.0167831444885022,-0.00685815924365609,3.06006721834254e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23531.Total Lipids in Large LDL,42679,-0.0125639226377325,0.00256542624573961,-0.0175921580793822,-0.00753568719608286,9.82381013318754e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23532.Phospholipids in Large LDL,42679,-0.0127658128182525,0.00254687346763022,-0.0177576848148077,-0.00777394082169728,5.4452217303831e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23533.Cholesterol in Large LDL,42679,-0.0165094429813414,0.00256845077994827,-0.02154360651004,-0.0114752794526428,1.33835840342196e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42679,-0.015138053719999,0.00256921348583131,-0.0201737121522283,-0.0101023952877696,3.90423649603388e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42679,-0.0198843814342945,0.00257079056411591,-0.0249231309399617,-0.0148456319286273,1.10950143430221e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23536.Triglycerides in Large LDL,42679,0.0408565637228716,0.00274130733804227,0.0354836013403087,0.0462295261054345,7.72998801385256e-50
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42679,-0.00314294520920769,0.0025504262464807,-0.00814178065230986,0.00185589023389449,0.217850480632969
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23538.Total Lipids in Medium LDL,42679,-0.00690972194020098,0.00256219602000953,-0.0119316261394197,-0.0018878177409823,0.00700969595578509
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23539.Phospholipids in Medium LDL,42679,-0.00935336734705644,0.00255573020215502,-0.0143625985432803,-0.00434413615083259,0.000253411738594943
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23540.Cholesterol in Medium LDL,42679,-0.00937220167360283,0.00255583083256805,-0.0143816301054362,-0.00436277324176945,0.000246367521031216
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42679,-0.00510254893397424,0.00257073879378846,-0.0101411969697996,-6.39008981488534e-05,0.0471806111688649
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42679,-0.0205553968553444,0.00254207784320571,-0.0255378694280276,-0.0155729242826612,6.68516162208249e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23543.Triglycerides in Medium LDL,42679,0.0372177305569595,0.00275723549239071,0.0318135489918737,0.0426219121220453,2.96865347283702e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23544.Concentration of Small LDL Particles,42679,-0.0010610718388569,0.00253585581804818,-0.00603134924223134,0.00390920556451754,0.675641238902563
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23545.Total Lipids in Small LDL,42679,-0.0085388958697691,0.00253600813501766,-0.0135094718144037,-0.00356831992513449,0.000761860332319928
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23546.Phospholipids in Small LDL,42679,-0.0129658481801895,0.00251403795942966,-0.0178933625806717,-0.00803833377970739,2.53978165390942e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23547.Cholesterol in Small LDL,42679,-0.0109639542764543,0.00253490420244144,-0.0159323665132395,-0.00599554203966908,1.5349261584598e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42679,-0.00514375893217265,0.00255247740183208,-0.0101466146397635,-0.000140903224581765,0.0439032363067844
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42679,-0.0249653344849446,0.00251983506236794,-0.0299042112071858,-0.0200264577627034,4.6286175723329e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23550.Triglycerides in Small LDL,42679,0.0353976544430433,0.00277596891925315,0.0299567553613072,0.0408385535247795,5.00539856046846e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42679,-0.0124759539191354,0.00290517244709353,-0.0181700919154388,-0.00678181592283212,1.76396673704216e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42679,-0.0149708447338834,0.00292015585891279,-0.0206943502173525,-0.00924733925041434,2.98902763299388e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42679,-0.0122828225289624,0.00294075759375597,-0.0180467074127241,-0.00651893764520067,2.9755804545992e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42679,-0.0226512167401219,0.00288475762349764,-0.0283053416821773,-0.0169970917980665,4.40130903978553e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42679,-0.0266785157642844,0.00291126301099805,-0.0323845912658406,-0.0209724402627282,5.71929195298406e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42679,-0.0082058301314825,0.00276686812585635,-0.013628891658161,-0.00278276860480405,0.00302478009636262
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42679,0.0376397076113802,0.00270157835778717,0.0323446140301173,0.042934801192643,8.08968630023434e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23558.Concentration of Large HDL Particles,42679,-0.0244620421225077,0.0030282301926596,-0.0303973733001205,-0.0185267109448949,7.13986996750965e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23559.Total Lipids in Large HDL,42679,-0.0215463879526796,0.00303532805333031,-0.027495630937207,-0.0155971449681522,1.32390675775117e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23560.Phospholipids in Large HDL,42679,-0.016713079328144,0.00303587704650857,-0.0226633983393008,-0.0107627603169872,3.75510399584886e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23561.Cholesterol in Large HDL,42679,-0.0309528616102558,0.00299653174451769,-0.0368260638295105,-0.0250796593910011,6.41485456495359e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42679,-0.0341341140057406,0.00298820741817177,-0.0399910005453573,-0.0282772274661239,4.41610789457967e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42679,-0.0198489091451528,0.00300985620827885,-0.0257482273133793,-0.0139495909769262,4.42181301514287e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23564.Triglycerides in Large HDL,42679,0.0442401715616335,0.00278359824199747,0.0387843190073185,0.0496960241159486,2.29434317875658e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42679,-0.00931976678230423,0.00283511973562485,-0.0148766014641289,-0.00376293210047952,0.00101427209899063
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23566.Total Lipids in Medium HDL,42679,-0.0045194186465229,0.00281377742274995,-0.0100344223951128,0.000995585102067008,0.108258902771484
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23567.Phospholipids in Medium HDL,42679,0.00208800749518368,0.00280059911374108,-0.00340116676774884,0.0075771817581162,0.455947797720423
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23568.Cholesterol in Medium HDL,42679,-0.0192696606945913,0.00282266316667093,-0.0248020805012663,-0.0137372408879163,9.0565095709562e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42679,-0.0211641029044118,0.00280699500870745,-0.0266658131214784,-0.0156623926873452,5.00822268333298e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42679,-0.0106370890267103,0.00287603242078731,-0.0162741125714535,-0.0050000654819672,0.000217713559378083
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23571.Triglycerides in Medium HDL,42679,0.0490925953524795,0.00269152769516278,0.0438172010699605,0.0543679896349986,1.90478783092534e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23572.Concentration of Small HDL Particles,42679,-0.0108070674796146,0.00260329742584767,-0.015909530434276,-0.00570460452495318,3.32624539669919e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23573.Total Lipids in Small HDL,42679,0.00445414896160858,0.00262636502024026,-0.000693526478062323,0.00960182440127949,0.0899209412336441
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23574.Phospholipids in Small HDL,42679,0.00970546513381959,0.00264142265651516,0.00452827672704989,0.0148826535405893,0.00023939567437318
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23575.Cholesterol in Small HDL,42679,-0.0151798145247242,0.00259903943971772,-0.0202739318265709,-0.0100856972228775,5.32284760604314e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42679,-0.0200439831262369,0.00258282134948738,-0.0251063129712321,-0.0149816532812416,9.06620470539177e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42679,0.00247059258164762,0.00266801131654552,-0.0027587095987816,0.00769989476207684,0.354459804729107
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23578.Triglycerides in Small HDL,42679,0.0459718700095226,0.00274527008988203,0.0405911406333538,0.0513525993856913,2.58405137771479e-62
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42186,0.00817726574917759,0.00267022172401969,0.00294363117009899,0.0134109003282562,0.00220024589158566
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42186,-0.019879543814174,0.00274840489974117,-0.0252664174176667,-0.0144926702106813,4.98470316178932e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42186,-0.0148153962161194,0.00272044612604843,-0.0201474706231743,-0.00948332180906444,5.24687546492871e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42186,-0.0228559797931879,0.00275804438525007,-0.0282617467882781,-0.0174502127980978,1.27440997156236e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42186,0.0133400584516751,0.00273129852354281,0.00798671334553117,0.018693403557819,1.05115719901356e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42561,0.00886686033183472,0.00265014461517149,0.0036725768860986,0.0140611437775708,0.000822707914869513
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42561,-0.0325792222148567,0.00276389541627011,-0.0379964572307462,-0.0271619871989673,6.5195937940387e-32
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42561,-0.034574558772424,0.00276553169706815,-0.0399950008986776,-0.0291541166461705,1.15280428531139e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42561,-0.0194699714741718,0.00273556931781929,-0.0248316873370976,-0.014108255611246,1.15643596518464e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42561,0.0253546262155335,0.0027159099405288,0.0200314427320971,0.03067780969897,1.16062267100252e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42678,0.0425555211904804,0.00268507205831806,0.037292779956177,0.0478182624247838,4.58291067509509e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42678,-0.0129042961129089,0.00263434328471487,-0.01806760895095,-0.00774098327486775,9.76981848273081e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42678,-0.0211811234459985,0.0027070765740112,-0.0264869935310604,-0.0158752533609365,5.48109050163417e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42678,0.0108741009946497,0.00260264801869141,0.0057729108780145,0.0159752911112848,2.95817364449138e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42678,-0.00490988132205304,0.00259151278484862,-0.00998924638035634,0.000169483736250256,0.0581667281684673
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42679,-0.0147681316809649,0.00262892187590296,-0.0199208185577347,-0.0096154448041951,1.9750154522714e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42679,-0.0303388833396464,0.00272027758254246,-0.0356706274014296,-0.0250071392778632,9.26345722899944e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42679,-0.032450816236237,0.00274756632464245,-0.0378360462325362,-0.0270655862399378,4.94009279001353e-32
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42679,-0.0233705606489207,0.00265894225321416,-0.0285820874652205,-0.018159033832621,1.68329207903127e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42679,0.0271631635247047,0.00269777108675429,0.0218755321946663,0.0324507948547431,9.21388056098271e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42679,-0.0406126374997964,0.00270095617768318,-0.0459065116080555,-0.0353187633915374,1.09153196670835e-50
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42679,-0.0225809218521538,0.00264871827059319,-0.0277724096625164,-0.0173894340417911,1.68593656572805e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42679,-0.00900598989970399,0.00260455344980228,-0.0141109146613165,-0.00390106513809153,0.000546313255333146
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42679,-0.0380088373366992,0.00271451027191066,-0.043329277469644,-0.0326883972037543,3.08741553607792e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42679,0.0283912996725294,0.00266755400477947,0.0231628938231616,0.0336197055218971,2.38639157937244e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42679,0.0245164147354202,0.00265538649800984,0.0193118571993209,0.0297209722715195,3.02696838395138e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42679,-0.033408073780299,0.00274235198203275,-0.0387830836650832,-0.0280330638955148,5.82663145639259e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42679,-0.0338639772680588,0.00276473796165332,-0.0392828636728993,-0.0284450908632183,2.60285975893732e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42679,-0.0223307032166647,0.00260871147151672,-0.0274437777008374,-0.0172176287324919,1.24916491038848e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42679,0.0320645718844945,0.00273254051695429,0.0267087924712641,0.0374203512977249,1.21101320845738e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42679,0.00758758185572359,0.00250760717594551,0.00267267179087038,0.0125024919205768,0.00248422711799849
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42679,-0.035466171001987,0.00263767273765413,-0.0406360095677891,-0.030296332436185,5.96402868399522e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42679,-0.0315964476742494,0.00263686147606713,-0.0367646961673409,-0.0264281991811578,6.44104259479754e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42679,-0.0251783504765649,0.00255023391058312,-0.0301768089413078,-0.0201798920118219,6.52149197652855e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42679,0.0458303455266661,0.00271275195214196,0.0405133517004679,0.0511473393528643,2.21627189605083e-63
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42679,-9.98675482776045e-05,0.0025487029863505,-0.00509532540152458,0.00489559030496937,0.968744529529415
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42679,-0.0590567100056852,0.00270731528972964,-0.0643630479735553,-0.0537503720378151,1.05624024058975e-103
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42679,-0.0362751644012411,0.00255023077636694,-0.0412736167229203,-0.0312767120795619,1.38358524115138e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42679,-0.0351442554343378,0.00273963178471971,-0.0405139337323885,-0.0297745771362872,1.88941440839754e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42679,0.0557914333986186,0.00270661976112527,0.050486458666813,0.0610964081304241,5.65848046665641e-93
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42679,-0.0181262652725927,0.00260613728322344,-0.0232342943477107,-0.0130182361974748,3.68227923015294e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42679,-0.0329838171888854,0.00252731108118855,-0.0379373469080149,-0.0280302874697558,1.07651525567261e-38
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42679,0.00967022499395795,0.00263097252663589,0.00451351884175161,0.0148269311461643,0.000238274289491849
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42679,-0.0458040413237547,0.00278660844978084,-0.0512657938853252,-0.0403422887621843,3.97781943960787e-60
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42679,0.0509396252340684,0.00266537900337363,0.0457154823874561,0.0561637680806807,2.32675140953107e-80
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42679,-0.0166728870277524,0.00257706132547623,-0.0217239272256858,-0.011621846829819,1.01569414602069e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42679,-0.0234951823463044,0.00259076852535824,-0.0285730886560065,-0.0184172760366022,1.36745166742503e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42679,0.0159390014656253,0.00257908614080632,0.0108839926296449,0.0209940103016057,6.5907309191551e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42679,-0.0480216929723124,0.00272841705665155,-0.0533693904033495,-0.0426739955412754,1.42259014465322e-68
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42679,0.0499013581795101,0.00272308987979195,0.0445641020151179,0.0552386143439023,4.11814906436472e-74
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42670,0.00109637136596057,0.00287482030055585,-0.0045382764231289,0.00673101915505003,0.702934434719213
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42670,-0.0297860459175444,0.00270112013424243,-0.0350802413806596,-0.0244918504544293,3.7236461343435e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42670,-0.0511120960343686,0.00259882795470901,-0.0562057988255982,-0.0460183932431389,6.34446458322447e-85
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42670,0.021904551002616,0.00300174049473165,0.016021139632942,0.02778796237229,3.10059096531667e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42670,0.0404278616169718,0.00284469502262597,0.0348522593726249,0.0460034638613187,1.65290170314274e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42679,0.0421429260059203,0.00277275781800602,0.0367083206826285,0.0475775313292121,9.64248481762077e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42679,-0.0556488673222708,0.00284564661116858,-0.0612263346801612,-0.0500713999643804,5.34507794693345e-84
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42679,-0.0619357786456757,0.00285595254496118,-0.0675334456337996,-0.0563381116575518,1.53808806427e-102
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42679,-0.00662085731865362,0.00273770209789446,-0.0119867534305268,-0.00125496120678047,0.0156021107265491
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42679,0.0543275403797551,0.00281212486273583,0.0488157756487928,0.0598393051107173,4.75529663043384e-82
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42679,0.0508429437080998,0.00279980438357867,0.0453553271162856,0.056330560299914,7.95267146920986e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42679,-0.0559094222670663,0.00276653469768767,-0.0613318302745341,-0.0504870142595985,1.70953675576503e-89
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42679,-0.0569695658346256,0.00274816380280892,-0.0623559668881311,-0.0515831647811201,5.38792693069562e-94
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42679,-0.0260515235820602,0.00293124452370832,-0.0317967628485285,-0.0203062843155919,7.0316469957045e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42679,0.0548541453367682,0.00272974375095936,0.0495038475848878,0.0602044430886485,1.60540758172687e-88
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42679,0.037423196911338,0.00270056164068419,0.032130096095597,0.042716297727079,2.26978459184767e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42679,-0.0586970559230731,0.0026644832921126,-0.0639194431756138,-0.0534746686705324,1.08882423620886e-105
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42679,-0.0575273746276069,0.00269331514346439,-0.0628062723087971,-0.0522484769464167,1.41431864956799e-99
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42679,-0.00715056246750859,0.00270692354384139,-0.0124561326134377,-0.00184499232157947,0.00826148551288769
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42679,0.0514498564267669,0.00276138581144002,0.0460375402363444,0.0568621726171893,1.61348027384672e-76
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52163,0.000257085547504923,0.0022577580099063,-0.00416812015191143,0.00468229124692127,0.909343723534343
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52163,0.000990392971137506,0.00219857795635234,-0.00331881982331307,0.00529960576558808,0.65237597745158
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50695,0.00261348572879885,0.00209666205385758,-0.00149597189676201,0.00672294335435971,0.212595085207045
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50695,0.00342783067641872,0.00230452022024497,-0.00108902895526142,0.00794469030809887,0.136913862242764
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50695,0.00326400317270768,0.0022486548452378,-0.00114336032395841,0.00767136666937377,0.146645290962582
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50695,0.000950417442527533,0.00204902729410605,-0.00306567605392032,0.00496651093897538,0.642768259462735
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24009.Traffic intensity on the nearest road,52163,0.00258644227494196,0.0917230553034752,-0.177190746119869,0.182363630669753,0.977504168130857
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24010.Inverse distance to the nearest road,52163,0.00413139134673086,0.00196908765723466,0.000271979538550916,0.0079908031549108,0.0359050310690396
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24011.Traffic intensity on the nearest major road,52163,0.00286366006114551,0.00194491890695857,-0.000948380996493282,0.00667570111878431,0.14093194241167
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24012.Inverse distance to the nearest major road,52163,0.00106510062715758,0.00198564025814502,-0.00282675427880665,0.00495695553312181,0.591686215212124
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24013.Total traffic load on major roads,52163,-0.0293752105800726,0.0645303974479194,-0.155854789577995,0.0971043684178494,0.648958809441694
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24015.Sum of road length of major roads within 100m,52163,-0.0068399553330432,0.0624787813668933,-0.129298366812154,0.115618456146068,0.912825554191536
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52163,-0.00124604865322665,0.0022422722801924,-0.00564090232240374,0.00314880501595045,0.578415896572348
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52163,-0.0012614195609488,0.00223757902473685,-0.00564707444943301,0.00312423532753542,0.572934537606113
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52163,-0.00114323679582437,0.00221217035702473,-0.00547909069559283,0.00319261710394409,0.605304809499534
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52109,0.000316482425489094,0.00220661394183774,-0.00400848090051287,0.00464144575149106,0.88595622305179
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24020.Average daytime sound level of noise pollution,52163,0.00198215935477292,0.00198337026767401,-0.00190524636986815,0.00586956507941398,0.317616588375187
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24021.Average evening sound level of noise pollution,52163,0.00204522764767482,0.00198366677301779,-0.00184275922744004,0.00593321452278968,0.302535788905023
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24022.Average night-time sound level of noise pollution,52163,0.00198481540509193,0.00198337743013275,-0.00190260435796826,0.00587223516815213,0.316970313265634
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52163,0.00201912770067968,0.00198350689503632,-0.00186854581359151,0.00590680121495086,0.308708401295026
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52163,0.00203143049227014,0.00198346228247152,-0.00185615558137404,0.00591901656591431,0.305759123075826
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2405.Number of children fathered,40136,-0.0174378179271797,0.0707524681072358,-0.156112655417362,0.121237019563003,0.805328987098759
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49857,0.000738562045328164,0.00229679220616118,-0.00376315067874775,0.00524027476940408,0.747787474771652
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49857,-0.00028454748246392,0.00206358837666786,-0.00432918070073292,0.00376008573580508,0.890328972637075
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24502.Water percentage, buffer 1000m",49857,0.00211658112687618,0.00209370798515163,-0.00198708652402102,0.00622024877777338,0.312064306230827
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49857,-0.000524905401708179,0.00215084082023279,-0.00474055340936444,0.00369074260594809,0.80719714772065
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49857,0.000811080274235264,0.00207261025229064,-0.00325123582025439,0.00487339636872492,0.695555327675419
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24505.Water percentage, buffer 300m",49857,0.000560721884482462,0.002109513741345,-0.00357392504855375,0.00469536881751867,0.790391100555455
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52309,0.00176164807165289,0.00221033447203069,-0.00257060749352727,0.00609390363683304,0.425456196550574
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52309,-0.000772261232774051,0.00206683897679195,-0.00482326562728627,0.00327874316173817,0.708672890511736
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24508.Distance (Euclidean) to coast,52309,-0.00282720646716995,0.0019503537489943,-0.00664989981519878,0.00099548688085888,0.147187429353956
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35576,0.0753688330742024,0.0858324818725893,-0.0928628313960726,0.243600497544477,0.379926739825424
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2704.Years since last cervical smear test,38494,0.0167196395278531,0.0749103031919339,-0.130104554728337,0.163543833784043,0.823388287748862
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2714.Age when periods started (menarche),40954,0.0630382099087425,0.059733501597506,-0.0540394532223693,0.180115873039854,0.291298755741458
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2734.Number of live births,41312,0.074855840787802,0.057670116848361,-0.0381775882349855,0.187889269810589,0.19431188027191
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2744.Birth weight of first child,39462,-0.175473754502399,0.0621069836264491,-0.297203442410239,-0.0537440665945589,0.00473207018015517
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2754.Age at first live birth,38222,-0.00574434613175659,0.00349762295394337,-0.0125996871214856,0.00111099485797241,0.10055082938124
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2764.Age at last live birth,38193,0.00276898127621732,0.00322558110579534,-0.00355315769114155,0.00909112024357618,0.390670110870921
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2794.Age started oral contraceptive pill,37129,-0.00674222278563437,0.00496116664618078,-0.0164661094121487,0.00298166384087996,0.1741853799379
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2804.Age when last used oral contraceptive pill,36338,-0.00551291647253184,0.00371720693069863,-0.0127986420567012,0.00177280911163747,0.138097175703129
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2867.Age started smoking in former smokers,36287,-0.00990855952436139,0.00380827951742743,-0.0173727873785191,-0.00244433167020363,0.00929159764779271
PLA2G15,Phospholipase A2 group XV,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36105,0.0683701123450789,0.101801660029291,-0.131161141312331,0.267901366002488,0.501860097954691
PLA2G15,Phospholipase A2 group XV,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36101,0.153232202458036,0.111275247873215,-0.0648672833734646,0.371331688289537,0.168539700282478
PLA2G15,Phospholipase A2 group XV,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36118,0.282526948156985,0.116116970120761,0.0549376867202948,0.510116209593676,0.0149943364144053
PLA2G15,Phospholipase A2 group XV,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36091,0.162369805176331,0.113452864798703,-0.0599978098291257,0.384737420181788,0.152428162337528
PLA2G15,Phospholipase A2 group XV,Mental health,X28739.Difficulty with standing for long periods,36125,0.28139286611388,0.0868040900068019,0.111256849700548,0.451528882527211,0.00119380820652388
PLA2G15,Phospholipase A2 group XV,Mental health,X28740.Difficulty with taking care of household responsibilities,36149,0.358696875272434,0.096720477975069,0.169124738441299,0.548269012103569,0.000210037671684972
PLA2G15,Phospholipase A2 group XV,Mental health,X28741.Difficulty learning a new task,36085,0.430856780757923,0.110647088691397,0.213988486922784,0.647725074593062,9.95478323238584e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28742.Difficulty with joining in community activities,35815,0.39900048246977,0.118985137375422,0.165789613213944,0.632211351725596,0.000802838556601414
PLA2G15,Phospholipase A2 group XV,Mental health,X28743.Difficulty with being emotionally affected by health problems,36105,0.290868341619561,0.0996233038488128,0.0956066660758879,0.486130017163234,0.00351521376513943
PLA2G15,Phospholipase A2 group XV,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36149,0.376544918411145,0.151442922082854,0.079716791128751,0.673373045693539,0.0129282424032621
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35804,0.318100370134823,0.0820417367191689,0.157298566165252,0.478902174104394,0.000106646192461323
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2897.Age stopped smoking,36285,0.0229504891706008,0.00358700289750902,0.0159199634914831,0.0299810148497185,1.67186077196958e-10
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35414,-0.00298147975594463,0.00791704353053464,-0.0184988850757925,0.0125359255639033,0.706491134661216
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35414,0.00158161013202085,0.00890433963798485,-0.0158708955584295,0.0190341158224712,0.859025319438659
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35414,0.0651403405306747,0.0292018972595597,0.00790462190193764,0.122376059159412,0.0257372827947755
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35414,-0.0465816177311096,0.0337254801560522,-0.112683558836972,0.0195203233747527,0.167267232173544
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35414,0.051786937149449,0.0419948495872717,-0.0305229680416035,0.134096842340501,0.217557628137951
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35414,-0.00237917341771841,0.0350385742905812,-0.0710547790272576,0.0662964321918207,0.94586618935905
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35414,-0.00472687020418924,0.0144293020884532,-0.0330083022975574,0.0235545618891789,0.743234012082718
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35414,0.0119091761588411,0.0245619328882843,-0.0362322123021961,0.0600505646198782,0.62779049776513
PLA2G15,Phospholipase A2 group XV,Mental health,X29002.Recent lack of interest or pleasure in doing things,35368,0.184369871421151,0.120194243935965,-0.0512108466933396,0.419950589535642,0.125097485450127
PLA2G15,Phospholipase A2 group XV,Mental health,X29003.Recent feelings of depression,35356,0.125399448209703,0.116258708677836,-0.102467620798856,0.353266517218263,0.280797554696748
PLA2G15,Phospholipase A2 group XV,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35369,0.13777900128289,0.0911271832109649,-0.0408302778106009,0.316388280376381,0.130599847275887
PLA2G15,Phospholipase A2 group XV,Mental health,X29005.Recent feelings of tiredness or low energy,35373,0.311212425938412,0.0901290478966246,0.134559492061028,0.487865359815796,0.000558181327996839
PLA2G15,Phospholipase A2 group XV,Mental health,X29006.Recent poor appetite or overeating,35384,0.277567236911419,0.138809582217146,0.00550045576581359,0.549634018057024,0.045584314464426
PLA2G15,Phospholipase A2 group XV,Mental health,X29007.Recent feelings of inadequacy,35348,0.107956232007682,0.131098427494969,-0.148996685882458,0.364909149897822,0.410270046309237
PLA2G15,Phospholipase A2 group XV,Mental health,X29008.Recent trouble concentrating on things,35383,0.00698348205249581,0.125934531372528,-0.239848199437658,0.25381516354265,0.955779145257099
PLA2G15,Phospholipase A2 group XV,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35376,0.442162757171487,0.21484914820017,0.0210584266991544,0.863267087643819,0.0396305423259182
PLA2G15,Phospholipase A2 group XV,Mental health,X29010.Recent thoughts of suicide or self-harm,35354,0.144787242849757,0.244241757769646,-0.333926602378749,0.623501088078263,0.553334778448756
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#0.Substances taken for depression_None of options listed,36397,-0.0413027985127172,0.0165095690359708,-0.07366155382322,-0.00894404320221429,0.0123801555357253
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36397,-0.0030598975473913,0.04278672021528,-0.0869218691693401,0.0808020740745574,0.942989774640452
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36397,-0.0186777638722876,0.0170750502140004,-0.0521448622917283,0.0147893345471532,0.2740516927585
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36397,0.0616270691006554,0.0528024110124391,-0.0418656564837253,0.165119794685036,0.243198107058936
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36397,-0.080649770366196,0.0431839560205925,-0.165290324166557,0.0039907834341653,0.0618603194921363
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36397,-0.0226314500671446,0.0472649222330358,-0.115270697643895,0.0700077975096055,0.632080318309778
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36397,-0.0015865263807699,0.0491464898660081,-0.0979136465181457,0.0947405937566059,0.974248392404891
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36397,0.0421542615033298,0.0461546463289745,-0.0483088453014602,0.13261736830812,0.361101418981174
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36397,-0.00754389362999387,0.0302071140627875,-0.0667498371930574,0.0516620499330697,0.80279633879281
PLA2G15,Phospholipase A2 group XV,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36397,-0.0295537951964687,0.0152129364459342,-0.0593711506304998,0.000263560237562417,0.0520943264853238
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36397,-0.0155367626630288,0.0270464385944749,-0.0685477823081997,0.037474256982142,0.565682865835626
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36397,-0.0479661854102098,0.0423356771541646,-0.130944112632372,0.0350117418119528,0.257253321239454
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36397,0.0210962566198725,0.0596776810415302,-0.0958719982215267,0.138064511461272,0.723721507900755
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36397,-0.0173976957851029,0.0400038274124713,-0.0958051975135467,0.0610098059433408,0.663647476629825
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36397,0.000733881396246362,0.057461915796234,-0.111891473564372,0.113359236356865,0.989810357266618
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36397,-0.117988944973552,0.0564513238655109,-0.228633539749953,-0.0073443501971502,0.0366437451953866
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36397,-0.045584670061046,0.0329587030347497,-0.110183728009155,0.0190143878870634,0.166681838372
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36397,-0.0484495924883108,0.0309631466046488,-0.109137359833422,0.0122381748568008,0.117685401829132
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36397,-0.06058909720802,0.0440685767881659,-0.146963507712825,0.0257853132967851,0.169210765713514
PLA2G15,Phospholipase A2 group XV,Mental health,X29058.Recent feelings or nervousness or anxiety,35275,-0.0297084023863345,0.106695258698129,-0.238831109434667,0.179414304661998,0.780682832112223
PLA2G15,Phospholipase A2 group XV,Mental health,X29059.Recent inability to stop or control worrying,35289,0.168704915233356,0.108974485847592,-0.0448850770279238,0.382294907494635,0.121646813831946
PLA2G15,Phospholipase A2 group XV,Mental health,X29060.Recent worrying too much about different things,35287,0.138446507736997,0.101418711175453,-0.0603341661668912,0.337227181640884,0.172272581465167
PLA2G15,Phospholipase A2 group XV,Mental health,X29061.Recent trouble relaxing,35282,0.191085633824867,0.109567053923315,-0.0236657918648308,0.405837059514565,0.081208475955611
PLA2G15,Phospholipase A2 group XV,Mental health,X29062.Recent restlessness,35299,0.139925312682481,0.16087086730677,-0.175381587238788,0.455232212603751,0.384444488464278
PLA2G15,Phospholipase A2 group XV,Mental health,X29063.Recent easy annoyance or irritability,35270,0.038679217732403,0.112367508878839,-0.181561099670121,0.258919535134927,0.730692264538061
PLA2G15,Phospholipase A2 group XV,Mental health,X29064.Recent feelings of foreboding,35270,0.165280170284058,0.12612397659035,-0.0819228238330282,0.412483164401144,0.190090503521669
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36397,-0.0401854142676404,0.019132341980418,-0.0776848045492597,-0.00268602398602114,0.0357290683127372
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36397,-0.076343274777784,0.0339683528571581,-0.142921246377814,-0.00976530317775408,0.0246393538959572
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36397,-0.0568944167203357,0.0419419792917866,-0.139100696132238,0.0253118626915661,0.174981726050817
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36397,-0.0560522766406067,0.0389647245996338,-0.132423136855889,0.0203185835746756,0.150324622526831
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#2.Symptoms of panic attack_Sweating,36397,-0.0305554891244253,0.0292413464317779,-0.0878685281307099,0.0267575498818593,0.296085188405758
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36397,-0.0171116595208571,0.0311806772978226,-0.0782257870245894,0.0440024679828752,0.583166239559505
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36397,-0.0308029690159941,0.0311650844165406,-0.0918865344724136,0.0302805964404255,0.322999418639366
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36397,-0.0318601019983867,0.0315093512297016,-0.0936184304086019,0.0298982264118284,0.311987392149651
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36397,-0.0443708721118237,0.0400546880806345,-0.122878060749867,0.03413631652622,0.268003645528993
PLA2G15,Phospholipase A2 group XV,Mental health,X29076.Felt loved as a child,35270,0.0172853105567151,0.0922877000592579,-0.163598581559431,0.198169202672861,0.851433172182575
PLA2G15,Phospholipase A2 group XV,Mental health,X29077.Physically abused by family as a child,35291,0.149465495492171,0.13845850820982,-0.121913180599076,0.420844171583418,0.280409109777231
PLA2G15,Phospholipase A2 group XV,Mental health,X29078.Felt hated by family member as a child,35276,0.0930467900022692,0.137570699928498,-0.176591781857586,0.362685361862125,0.498840277732053
PLA2G15,Phospholipase A2 group XV,Mental health,X29079.Sexually molested as a child,35233,0.0450556854492756,0.175661619321549,-0.299241088420961,0.389352459319512,0.79758020207302
PLA2G15,Phospholipase A2 group XV,Mental health,X29080.Someone to take to doctor when needed as a child,35249,0.140663418578569,0.129974112159903,-0.114085841254841,0.395412678411979,0.279188212669767
PLA2G15,Phospholipase A2 group XV,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35282,-0.103241128369313,0.203457481154023,-0.502017791431198,0.295535534692573,0.611869115296633
PLA2G15,Phospholipase A2 group XV,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35238,0.0509334816908394,0.152624907575703,-0.248211337157538,0.350078300539217,0.738604919612925
PLA2G15,Phospholipase A2 group XV,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35288,-0.00578851214795406,0.177235741613962,-0.353170565711319,0.341593541415411,0.973946824273565
PLA2G15,Phospholipase A2 group XV,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35275,0.0592501202702152,0.243687548190389,-0.418377474182948,0.536877714723378,0.807905370583714
PLA2G15,Phospholipase A2 group XV,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35276,-0.442661647046949,0.227793361896269,-0.889136636363635,0.00381334226973801,0.0520308784145464
PLA2G15,Phospholipase A2 group XV,Mental health,X29086.Experienced a violent or sexual assault,35290,-0.147309595485014,0.216381577728512,-0.571417487832897,0.276798296862869,0.496032634342733
PLA2G15,Phospholipase A2 group XV,Mental health,X29087.Experienced a life-threatening injury or illness,35284,0.0981139891169455,0.104006096832274,-0.105737960674311,0.301965938908202,0.345540134310093
PLA2G15,Phospholipase A2 group XV,Mental health,X29088.Experienced a marital separation or divorce,35289,-0.0197900930667977,0.105054673670635,-0.225697253461242,0.186117067327646,0.850585842781373
PLA2G15,Phospholipase A2 group XV,Mental health,X29089.Experienced the death of a spouse or partner,35297,0.0975433471729685,0.113644644656681,-0.125200156354127,0.320286850700064,0.390750104841297
PLA2G15,Phospholipase A2 group XV,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35287,-0.0824328864660859,0.134349092324402,-0.345757107421914,0.180891334489742,0.539520876792617
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29091.Frequency of drinking alcohol,35288,-0.209721749085417,0.083894149294867,-0.374154281703356,-0.0452892164674776,0.0124511208092356
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34536,0.0253969588028622,0.104334519597654,-0.17909869960854,0.229892617214264,0.807690517043125
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34558,-0.0369818654605989,0.109232444279276,-0.25107745624798,0.177113725326782,0.734953588056107
PLA2G15,Phospholipase A2 group XV,Mental health,X29104.Ever used cannabis,35289,-0.383125037906018,0.15753168097562,-0.691887132618234,-0.0743629431938024,0.0150422219691737
PLA2G15,Phospholipase A2 group XV,Mental health,X29108.Ever thought that life not worth living,35255,-0.0328890839787946,0.115506679426647,-0.259282175655022,0.193504007697433,0.775854982434978
PLA2G15,Phospholipase A2 group XV,Mental health,X29109.Ever contemplated self-harm,35280,-0.0933681027843928,0.174380038674005,-0.435152978585443,0.248416773016658,0.592372915346344
PLA2G15,Phospholipase A2 group XV,Mental health,X29111.Ever self-harmed,35289,0.148135612402389,0.304132600994229,-0.447964285546301,0.744235510351078,0.626222174857945
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35276,-0.225273809946606,0.173330494212775,-0.565001578603646,0.114453958710434,0.193760658836464
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,37025,-0.0783297749594846,0.0453904425468398,-0.167295042351291,0.0106354924323215,0.0844428754130573
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,37025,-0.0949324978753898,0.0335416889507228,-0.160674208218807,-0.029190787531973,0.00466251625623887
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,37025,-0.0847064103840393,0.0399305043897178,-0.162970198987886,-0.00644262178019253,0.033924033236068
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,37025,-0.191214701080448,0.0568460482186362,-0.302632955588975,-0.0797964465719215,0.000772659814786319
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35268,-0.16091250812118,0.0978690759262897,-0.352735896936708,0.0309108806943476,0.100194730554893
PLA2G15,Phospholipase A2 group XV,Health and medical history,X29153.Pain or discomfort today,35280,0.230584399897324,0.0892021883869671,0.0557481106588684,0.40542068913578,0.00976199419646675
PLA2G15,Phospholipase A2 group XV,Mental health,X29154.Anxiety or depression today,35280,0.063516191521098,0.114918626611177,-0.161724316636809,0.288756699679005,0.580485189403304
PLA2G15,Phospholipase A2 group XV,Mental health,X29166.Frequency of confiding in someone close,35098,-0.0529108942909479,0.0874770141311309,-0.224365841987964,0.118544053406069,0.545298720906477
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35261,0.0185512604533287,0.00768960950068869,0.00347962583197884,0.0336228950746785,0.0158725754667088
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35261,-0.0219839271522062,0.00787043078224305,-0.0374099714854025,-0.00655788281900978,0.00523480688952646
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35261,0.00970367901391588,0.00984464706443586,-0.0095918292323784,0.0289991872602102,0.324329109428711
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35261,-0.0122247351785802,0.00913013637215938,-0.0301198024680126,0.00567033211085218,0.180639286726392
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35261,-0.0411602086426329,0.015575799020211,-0.0716887747222464,-0.0106316425630194,0.00824897055713459
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35261,-0.0175203262788936,0.00744195689286187,-0.0321065617889029,-0.00293409076888434,0.0185911590927563
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35259,0.0057366820505126,0.00799488318761915,-0.00993328899722093,0.0214066530982461,0.473066009492215
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35259,-0.00443579464400381,0.0122972008378903,-0.0285383082862689,0.0196667189982612,0.718324474201106
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35259,0.00532272414703519,0.0178922687727311,-0.0297461226475178,0.0403915709415881,0.766104630664551
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35259,-0.00384153753309763,0.014354464415437,-0.0319762877873541,0.0242932127211588,0.789001161730754
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35259,-0.0244048225584332,0.0239213017970783,-0.0712905740807066,0.0224809289638402,0.307668156251811
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35259,-0.00194620915271247,0.0108420656999405,-0.0231966579245959,0.0193042396191709,0.857546887638619
PLA2G15,Phospholipase A2 group XV,Mental health,X29171.Frequency of feeling 'in tune' with people,35156,0.0290068189828142,0.112565579328879,-0.191621716501788,0.249635354467416,0.796656466100538
PLA2G15,Phospholipase A2 group XV,Mental health,X29172.Freuency of feeling that lacks companionship,35241,0.0172632187127063,0.101124657123755,-0.180941109249854,0.215467546675266,0.86445573497019
PLA2G15,Phospholipase A2 group XV,Mental health,X29173.Frequency of feeling left out,35199,-0.0795681860192564,0.108220311127732,-0.291679995829612,0.132543623791099,0.462220459629635
PLA2G15,Phospholipase A2 group XV,Mental health,X29174.Frequency of feeling isolated from others,35232,0.0324302332073617,0.111702775528271,-0.186507206828049,0.251367673242772,0.771576731392148
PLA2G15,Phospholipase A2 group XV,Mental health,X29175.Tendency to bounce back quickly after hard times,35275,-0.0520794459395114,0.089009649216449,-0.226538358403751,0.122379466524729,0.558502952921537
PLA2G15,Phospholipase A2 group XV,Mental health,X29176.Ability to make it through stressful events,35275,-0.0402045995216763,0.0848518375977164,-0.2065142012132,0.126105002169848,0.635644434343166
PLA2G15,Phospholipase A2 group XV,Mental health,X29177.Quick recovery from stressful events,35275,0.0518183314959073,0.0877382763216645,-0.120148690094555,0.22378535308637,0.554809617851276
PLA2G15,Phospholipase A2 group XV,Mental health,X29178.Hard to snap back when something bad happens,35275,-0.0386348835943787,0.0853340763176086,-0.205889673176892,0.128619905988134,0.650745939102658
PLA2G15,Phospholipase A2 group XV,Mental health,X29179.Comes through difficult times with little trouble,35275,0.130649815931898,0.0874722743875645,-0.0407958418677279,0.302095473731525,0.135328439246561
PLA2G15,Phospholipase A2 group XV,Mental health,X29180.Tendency to take a long time to get over setbacks,35275,-0.0214289173401897,0.0858629060924533,-0.189720213281398,0.146862378601019,0.802927327180276
PLA2G15,Phospholipase A2 group XV,Mental health,X29181.General happiness,35246,-0.023431880236485,0.0901400646228892,-0.200106406897348,0.153242646424378,0.794911443723272
PLA2G15,Phospholipase A2 group XV,Mental health,X29182.Belief that own life is meaningful,35152,0.0579997396721757,0.0901809583005471,-0.118754938596897,0.234754417941248,0.520152570596528
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35612,-0.058675672879408,0.075221089467467,-0.206109008235643,0.0887576624768273,0.435394420038339
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2946.Father's age,30168,-0.0392440164683315,0.0173583791256458,-0.0732664395545973,-0.00522159338206576,0.0239909406031239
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2966.Age high blood pressure diagnosed,36838,-0.0091909667578075,0.00381690461100694,-0.0166720997953811,-0.00170983372023391,0.0160653182064607
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30000.White blood cell (leukocyte) count,51701,0.0154614610985386,0.00213960166766174,0.0112678418299216,0.0196550803671556,5.12057164886874e-13
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51702,0.00337855190526794,0.0022521185284731,-0.00103560041053933,0.00779270422107521,0.133585404221029
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30020.Haemoglobin concentration,51702,0.0131979253244633,0.00241974376976606,0.00845522753572181,0.0179406231132048,4.96933592414293e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30030.Haematocrit percentage,51702,0.00994731623856064,0.00235462446100624,0.00533225229498842,0.0145623801821329,2.40320542092089e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30040.Mean corpuscular volume,51702,0.00841396408337385,0.00206681670206731,0.00436300334732191,0.0124649248194258,4.69761986287054e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51702,0.0106473923019024,0.002072399285604,0.00658548970211853,0.0147092949016862,2.80423278233164e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51702,0.00384023265603134,0.00203154520944981,-0.00014159595449029,0.00782206126655296,0.0587305027280327
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51702,0.0203979773025926,0.00209203222480111,0.0162975941419825,0.0244983604632028,2.03681531209199e-22
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30080.Platelet count,51702,0.013255131863714,0.00205074322137367,0.00923567514982159,0.0172745885776064,1.04353050780754e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30090.Platelet crit,51702,0.0112016780810878,0.00208793326097157,0.00710932888958349,0.0152940272725921,8.17665930740324e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51702,-0.00847026155936444,0.00195686255942495,-0.0123057121758373,-0.00463481094289154,1.50782351744066e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30110.Platelet distribution width,51702,0.01219327064367,0.00202916525796303,0.00821610673806247,0.0161704345492776,1.89531711819063e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30120.Lymphocyte count,51662,0.00505575134510588,0.00201527255519588,0.00110581713692195,0.0090056855532898,0.0121239877543645
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30130.Monocyte count,51662,0.0267902506337532,0.00205708759161664,0.0227583589541846,0.0308221423133218,1.24333699600122e-38
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30140.Neutrophill count,51662,0.0094342580194114,0.00212110163576254,0.00527689881331682,0.013591617225506,8.71660664154363e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30150.Eosinophill count,51662,0.0123596585087328,0.00202286910603709,0.00839483506090011,0.0163244819565655,1.01292039006593e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30160.Basophill count,51662,0.0938624816707777,0.0461854699439424,0.00333896058065053,0.184386002760905,0.0421355779356555
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30170.Nucleated red blood cell count,51662,0.784430346506075,0.216597973501114,0.359898318443892,1.20896237456826,0.000293435570100335
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30180.Lymphocyte percentage,51663,-0.00556298284336976,0.00200784680731289,-0.00949836258570302,-0.0016276031010365,0.00559954429047128
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30190.Monocyte percentage,51663,0.0190221246374311,0.00203379617556217,0.0150358841333292,0.0230083651415329,9.29145669617321e-21
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30200.Neutrophill percentage,51663,-0.00316626697967064,0.0019932143013763,-0.00707296701036818,0.000740433051026895,0.112182169832792
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30210.Eosinophill percentage,51663,0.00748888512058979,0.00200771955720116,0.00355375478847552,0.0114240154527041,0.000191915936899984
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30220.Basophill percentage,51663,-0.000223300644506315,0.00200338008295084,-0.00414992560708996,0.00370332431807733,0.911251035065786
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30230.Nucleated red blood cell percentage,51662,0.784831951833842,0.216736234455234,0.360028932301584,1.2096349713661,0.000293954531159232
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30240.Reticulocyte percentage,51316,0.0387817770187012,0.0021520221067341,0.0345638136895023,0.0429997403479,4.36487909579862e-72
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30250.Reticulocyte count,51316,0.0392006355032372,0.00219132602220333,0.0349056364997187,0.0434956345067557,4.55276129882317e-71
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30260.Mean reticulocyte volume,51316,0.0125019410414103,0.00202624635723445,0.00853049818123075,0.0164733839015898,6.94751750426295e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30270.Mean sphered cell volume,51316,0.0087055263120368,0.00205446533039837,0.004678774264456,0.0127322783596176,2.27070324556568e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30280.Immature reticulocyte fraction,51316,0.0218868103384466,0.00213245585057285,0.0177071968713238,0.0260664238055693,1.16688798257293e-24
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51316,0.0402534138174785,0.00219168835259452,0.0359577046463932,0.0445491229885637,8.78404857823133e-75
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30300.High light scatter reticulocyte count,51316,0.0407713793565046,0.00222180967113093,0.036416632401088,0.0451261263119213,1.17131780830861e-74
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30500.Microalbumin in urine,37207,0.0243245423722826,0.0034601605889685,0.0175426276179044,0.0311064571266609,2.23675460448642e-12
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51694,-0.00110621462235764,0.00223537975565798,-0.00548755894344728,0.00327512969873201,0.620699170292535
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30520.Potassium in urine,51656,-0.00613814833320576,0.00209901952994466,-0.0102522266118973,-0.00202407005451423,0.00345584407218943
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30530.Sodium in urine,51636,0.00329624525480452,0.00220697491102234,-0.00102942557079927,0.00762191608040831,0.135305216432177
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30600.Albumin,49443,-0.000951629828001396,0.00215806696101751,-0.00518144107159572,0.00327818141559292,0.65924377107389
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30610.Alkaline phosphatase,51277,0.0378316331851508,0.00211784201991189,0.0336806628261235,0.0419826035441781,7.18630062237599e-71
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30620.Alanine aminotransferase,51280,0.0606569509842825,0.00223800370651373,0.0562704637195156,0.0650434382490494,3.61863760452313e-159
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30630.Apolipoprotein A,49299,-0.021802500362867,0.00236028701241956,-0.0264286629072093,-0.0171763378185246,2.77458587040324e-20
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30640.Apolipoprotein B,51177,0.00296449368884586,0.00197933277215144,-0.00091499854457096,0.00684398592226268,0.134219398294534
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30650.Aspartate aminotransferase,51214,0.0699493344326319,0.00212126158147805,0.0657916617329349,0.0741070071323289,8.28950984449678e-233
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30660.Direct bilirubin,48041,0.0153871521158459,0.00231437873170987,0.0108509698016946,0.0199233344299973,3.04205172116871e-11
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30670.Urea,51263,-0.0380705566231895,0.00208629768400167,-0.0421597000838327,-0.0339814131625462,7.51230582148176e-74
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30680.Calcium,49445,0.00561497455834203,0.00209181942323115,0.00151500848880898,0.00971494062787509,0.00727510000431992
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30690.Cholesterol,51283,-0.00550584952502195,0.00199989324072143,-0.00942564027683596,-0.00158605877320794,0.0059087179435385
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30700.Creatinine,51274,-0.0131729744847913,0.00233126114605874,-0.0177422463310665,-0.00860370263851622,1.61878760428682e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30710.C-reactive protein,51221,0.0425413497231083,0.00225296690937994,0.0381255345807236,0.0469571648654929,6.69231562415583e-79
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30720.Cystatin C,51290,0.0552828715425169,0.00227912692391896,0.0508157827716358,0.0597499603133981,2.7064929073907e-128
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30730.Gamma glutamyltransferase,51277,0.070382361142369,0.00223513662021889,0.06600149336674,0.074763228917998,6.19566894449547e-213
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30740.Glucose,49428,0.0238030589515725,0.0021406236512585,0.0196074365951058,0.0279986813080392,1.2182590804292e-28
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51245,0.0136001233585276,0.00219470664516974,0.0092984983339949,0.0179017483830603,5.86492738001466e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30760.HDL cholesterol,49435,-0.0371446101207725,0.00241501712039759,-0.0418780436767518,-0.0324111765647932,4.40572397891292e-53
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30770.IGF-1,51153,-0.0510466396519378,0.00205772005035525,-0.0550797709506341,-0.0470135083532415,5.21465987141532e-134
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30780.LDL direct,51231,-0.00274808280486873,0.00196080658179862,-0.00659126370519402,0.00109509809545656,0.161076804043908
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30790.Lipoprotein A,46801,-0.00885113476783292,0.00223038746790792,-0.0132226942049324,-0.0044795753307334,7.26348008007663e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30810.Phosphate,49408,-0.00793479679842763,0.00224469533027424,-0.0123343996457651,-0.00353519395109013,0.000408824934131848
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30830.SHBG,49269,0.0309964660144771,0.00259021592815703,0.0259196427952893,0.0360732892336649,6.86670578905945e-33
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30840.Total bilirubin,51192,0.00444443822776805,0.0021977176349039,0.0001369116633564,0.00875196479217969,0.043157734899841
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30850.Testosterone,48703,0.018857595352052,0.00347456763963264,0.012047442778372,0.0256677479257319,5.78880781714919e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30860.Total protein,49427,0.0384264933829259,0.0020755292839104,0.0343584559864615,0.0424945307793903,6.7382193555038e-76
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30870.Triglycerides,51268,0.0356275382347536,0.00227488491279474,0.0311687638056759,0.0400863126638312,5.50500833331861e-55
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30880.Urate,51250,0.0136524159513037,0.00245618441760518,0.00883829449279754,0.0184665374098099,2.75433392620317e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30890.Vitamin D,50159,-0.0218902766459828,0.00231230813090208,-0.0264224005825508,-0.0173581527094147,3.17983837301133e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X3137.Number of measurements made,49833,-0.0185984798970974,0.0547282005276696,-0.12586575293133,0.088668793137135,0.733985322115344
PLA2G15,Phospholipase A2 group XV,Physical measures,X3143.Ankle spacing width,42326,0.015688130260006,0.0035020852619849,0.00882404314651556,0.0225522173734964,7.53954351670429e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42325,-0.00837171778194506,0.00272931615963106,-0.0137211774548219,-0.00302225810906818,0.00216418576374545
PLA2G15,Phospholipase A2 group XV,Physical measures,X3146.Speed of sound through heel,42326,-0.0131743295410773,0.002612616330679,-0.0182950575492081,-0.00805360153294644,4.65418385552197e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42326,-0.0119857653761084,0.002645470639759,-0.0171708878300361,-0.0068006429221808,5.93143062795831e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X3148.Heel bone mineral density (BMD),42315,-0.0128908752831293,0.00264581226934068,-0.018076667331037,-0.00770508323522154,1.11662450127711e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3526.Mother's age at death,48437,-0.00646203868111105,0.0021089349918241,-0.0105955512650863,-0.00232852609713581,0.00218610192268797
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3581.Age at menopause (last menstrual period),38538,-0.00874095785996759,0.00281724291828176,-0.0142627539797998,-0.00321916174013534,0.00192359348243157
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32826,0.000630866843467506,0.0044421374006111,-0.00807572246173024,0.00933745614866526,0.887073064821264
PLA2G15,Phospholipase A2 group XV,Physical measures,X4100.Ankle spacing width (left),36792,0.0141435637345959,0.00473022393441518,0.00487232482314213,0.0234148026460496,0.0027983379093936
PLA2G15,Phospholipase A2 group XV,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36789,-0.0137161344114474,0.00367469999893154,-0.0209185464093532,-0.00651372241354159,0.000190908070476483
PLA2G15,Phospholipase A2 group XV,Physical measures,X4103.Speed of sound through heel (left),36792,-0.0186527889574023,0.0035036195416891,-0.025519883259113,-0.0117856946556917,1.04492569195844e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36792,-0.0175272998645523,0.00355251544370555,-0.0244902301342152,-0.0105643695948895,8.23708872087371e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X4105.Heel bone mineral density (BMD) (left),36787,-0.017325299046308,0.00355253791292502,-0.0242882733556411,-0.010362324736975,1.09968297599415e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36792,-0.0175240702822067,0.00355250964864573,-0.0244869891935524,-0.0105611513708611,8.27507019945071e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X4119.Ankle spacing width (right),36792,0.0113808834516755,0.0046664940530021,0.00223455510779141,0.0205272117955596,0.0147567822236022
PLA2G15,Phospholipase A2 group XV,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36791,-0.0176299640858074,0.00366839904290902,-0.0248200262099091,-0.0104399019617057,1.57012878047307e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X4122.Speed of sound through heel (right),36792,-0.0195498590428407,0.00349743955664622,-0.0264048405738673,-0.0126948775118141,2.35257584818589e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36792,-0.0191995544084964,0.00354679785276454,-0.0261512781999149,-0.0122478306170779,6.37958674153051e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4124.Heel bone mineral density (BMD) (right),36787,-0.018710975464187,0.00354502240952939,-0.0256592193868646,-0.0117627315415093,1.34143761403073e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36792,-0.0191990146760546,0.00354679583974976,-0.0261507345219641,-0.0122472948301451,6.38488289924807e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4194.Pulse rate,37146,0.0326796761067652,0.0033450328782251,0.026123411665444,0.0392359405480864,2.03192952788451e-22
PLA2G15,Phospholipase A2 group XV,Physical measures,X4195.Pulse wave reflection index,37146,-0.00739368074379959,0.0036491686419727,-0.0145460512820661,-0.000241310205533096,0.0427850442620935
PLA2G15,Phospholipase A2 group XV,Physical measures,X4196.Pulse wave peak to peak time,37141,-0.0129209088225828,0.0033208321018635,-0.0194297397422352,-0.00641207790293031,0.000100703157047882
PLA2G15,Phospholipase A2 group XV,Physical measures,X4198.Position of the pulse wave peak,37146,0.0218463228714644,0.00354063030904294,0.0149066874657402,0.0287859582771885,7.15513697776113e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X4199.Position of pulse wave notch,37146,0.0238819064091489,0.00339058377988971,0.0172363622005651,0.0305274506177327,2.02971509163625e-12
PLA2G15,Phospholipase A2 group XV,Physical measures,X4200.Position of the shoulder on the pulse waveform,37146,0.022059895651319,0.00348624129971381,0.0152268627038799,0.028892928598758,2.62309685933337e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X4269.Number of triplets attempted (left),36957,-0.168329292213149,0.201927460678414,-0.564107115142841,0.227448530716543,0.404524970652627
PLA2G15,Phospholipase A2 group XV,Physical measures,X4270.Volume level set by participant (left),36864,0.130469669865531,0.0704591352194117,-0.00763023516451608,0.268569574895578,0.0641063372949309
PLA2G15,Phospholipase A2 group XV,Physical measures,X4276.Number of triplets attempted (right),36954,-0.179126669875871,0.196129897336839,-0.563541268656075,0.205287928904333,0.361109894269733
PLA2G15,Phospholipase A2 group XV,Physical measures,X4277.Volume level set by participant (right),36858,0.0926496908411605,0.0693840538375303,-0.0433430546803989,0.22864243636272,0.18181236478961
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4288.Time to answer,37150,-0.00343461718207565,0.00396772503876731,-0.0112113582580596,0.00434212389390828,0.386714311708604
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4290.Duration screen displayed,37150,0.0149831730945747,0.003750740147376,0.00763172240571776,0.0223346237834317,6.53533107279192e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X46.Hand grip strength (left),52306,-0.030987923405448,0.00287107549028231,-0.0366152313664013,-0.0253606154444947,4.30397898909797e-27
PLA2G15,Phospholipase A2 group XV,Physical measures,X47.Hand grip strength (right),52332,-0.028574125451142,0.00285257808324585,-0.0341651784943039,-0.0229830724079802,1.4342747621568e-23
PLA2G15,Phospholipase A2 group XV,Physical measures,X48.Waist circumference,52396,0.0528287273835009,0.00435295292557966,0.0442969396493647,0.061360515117637,8.58743658778282e-34
PLA2G15,Phospholipase A2 group XV,Health and medical history,X4803.Tinnitus,37053,0.093904744526834,0.0780628794378318,-0.0590984991713164,0.246907988224984,0.229036860573615
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4825.Noisy workplace,37131,0.204344876383974,0.0885684254584328,0.0307507624854456,0.377938990282502,0.0210694123904918
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4836.Loud music exposure frequency,37088,0.213394019102948,0.145210591984952,-0.0712187411875584,0.498006779393455,0.141723916679491
PLA2G15,Phospholipase A2 group XV,Physical measures,X49.Hip circumference,52391,-0.0195865784426836,0.0035580805941044,-0.0265604164071282,-0.0126127404782389,3.73467097429111e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X50.Standing height,52372,0.00417590783554659,0.00282535724441497,-0.00136179236350676,0.00971360803459994,0.139418540597352
PLA2G15,Phospholipase A2 group XV,Health and medical history,X5057.Number of older siblings,35910,0.187167353112633,0.0765378085803368,0.0371532482951725,0.337181457930093,0.014493720323092
PLA2G15,Phospholipase A2 group XV,Physical measures,X51.Seated height,52278,-0.000535385539059078,0.00264004232596673,-0.00570986849795387,0.00463909741983571,0.839297599538582
PLA2G15,Phospholipase A2 group XV,Eye measures,X5181.Ever had eye surgery,34535,0.203838974181381,0.152132840723954,-0.0943413936375687,0.50201934200033,0.180343043788171
PLA2G15,Phospholipase A2 group XV,Eye measures,X5186.Duration visual-acuity screen displayed (right),34521,0.00477112054199076,0.00410818665682273,-0.00328092530538179,0.0128231663893633,0.245543914849798
PLA2G15,Phospholipase A2 group XV,Eye measures,X5188.Duration visual-acuity screen displayed (left),34521,0.00514615784274848,0.00421284281107589,-0.00311101406696027,0.0134033297524572,0.22193552104135
PLA2G15,Phospholipase A2 group XV,Eye measures,X5190.Duration at which refractometer first shown (right),34447,0.00348805514862512,0.00433490634146656,-0.00500836128064933,0.0119844715778996,0.421061722279563
PLA2G15,Phospholipase A2 group XV,Eye measures,X5193.Duration at which refractometer first shown (left),34446,0.00309009787920277,0.00437149833835213,-0.00547803886396741,0.0116582346223729,0.479676233256038
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5199.logMAR, initial (right)",34504,0.144168606041059,0.0891861171144562,-0.0306361835032747,0.318973395585394,0.106047489633553
PLA2G15,Phospholipase A2 group XV,Eye measures,X5200.Final number of letters displayed (right),34504,-0.275207343273175,0.505999390375694,-1.26696614840953,0.716551461863185,0.586540918456752
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5201.logMAR, final (right)",34446,0.00351449151249816,0.00454795168283901,-0.00539949378586631,0.0124284768108626,0.439697074162152
PLA2G15,Phospholipase A2 group XV,Eye measures,X5202.Number of rounds to result (right),34504,0.114605316291125,0.0812722324845565,-0.0446882593786058,0.273898891960856,0.158556712794678
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5206.logMAR, initial (left)",34501,0.0587507675030852,0.0893134736605577,-0.116303640871608,0.233805175877778,0.510692567267712
PLA2G15,Phospholipase A2 group XV,Eye measures,X5207.Final number of letters displayed (left),34501,-0.622813907743846,0.456983306191016,-1.51850118787824,0.272873372390545,0.172977834076109
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5208.logMAR, final (left)",34439,0.00261410094070049,0.00453767175963915,-0.00627973570819224,0.0115079375895932,0.564580018794839
PLA2G15,Phospholipase A2 group XV,Eye measures,X5209.Number of rounds to result (left),34499,-0.00994463233090486,0.0816504259020245,-0.169979467098873,0.150090202437063,0.903065815066369
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34244,0.000514688235331647,0.00425893159752772,-0.00783281769582268,0.00886219416648597,0.903815332324651
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34244,0.00572174595763834,0.00430184107123101,-0.00270986254197443,0.0141533544572511,0.183555565028809
PLA2G15,Phospholipase A2 group XV,Eye measures,X5256.Corneal hysteresis (right),34244,0.00805297103737354,0.00429064890210378,-0.000356700810749877,0.016462642885497,0.0605941365902878
PLA2G15,Phospholipase A2 group XV,Eye measures,X5257.Corneal resistance factor (right),34244,0.00958975011445147,0.00432423207837584,0.00111425524083483,0.0180652449880681,0.0266212041382542
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34237,-0.000801294149346622,0.00423180599724007,-0.00909563390393715,0.00749304560524391,0.849825817958434
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34237,0.00297888982759251,0.00426897400394185,-0.00538829922013351,0.0113460788753185,0.485334483836695
PLA2G15,Phospholipase A2 group XV,Eye measures,X5264.Corneal hysteresis (left),34237,0.00608128973721912,0.00432452621719378,-0.00239478164848069,0.0145573611229189,0.159716680221667
PLA2G15,Phospholipase A2 group XV,Eye measures,X5265.Corneal resistance factor (left),34237,0.00676330279006296,0.00433783741431489,-0.00173885854199423,0.0152654641221202,0.119025617012536
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34640,0.755501013631472,0.434651486923813,-0.0964159007392015,1.60741792800215,0.0822362433719653
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52332,0.0255689550036571,0.0106363140328394,0.00472177949929176,0.0464161305080223,0.0162276889767198
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52332,0.0391233522854095,0.0113003015526041,0.0169747612423055,0.0612719433285134,0.000536843908903742
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52332,-0.0373863878184668,0.0303640050856232,-0.0968998377862883,0.0221270621493547,0.218233190453784
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52332,-0.00768958655165038,0.00458601559605049,-0.0166781771199093,0.00129900401660857,0.0936055314331362
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52332,-0.00290968602472767,0.00431944815888792,-0.011375804416148,0.00555643236669264,0.500556813595129
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38349,-0.0269265002608968,0.00628285909885939,-0.0392409040946612,-0.0146120964271324,1.84022478692344e-05
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38349,0.0158614565139695,0.0134950855136171,-0.0105889110927201,0.0423118241206591,0.2398850546856
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38349,-0.0333363914630167,0.0165305097593105,-0.0657361905912653,-0.000936592334768019,0.0437603142937804
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38349,0.0185780028318879,0.00892265857121868,0.00108959203229925,0.0360664136314765,0.0373596539340387
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52408,0.00537192910289148,0.00898532670736108,-0.0122393112435362,0.0229831694493192,0.549942029889065
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52408,0.00537192910289148,0.00898532670736108,-0.0122393112435362,0.0229831694493192,0.549942029889065
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52408,0.00154859519490151,0.00717642246052904,-0.0125171928277354,0.0156143832175384,0.829153883385721
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52408,-0.0112654533045421,0.0124002858355912,-0.0355700135423008,0.0130391069332166,0.363632334072779
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52408,0.0220061999924707,0.0298317781558196,-0.0364640851929357,0.0804764851778771,0.460718546842229
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52408,0.0129776635612363,0.0203901837023241,-0.026987096495319,0.0529424236177916,0.524478853673288
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52408,0.0543558190642016,0.0331244414861364,-0.0105680862486257,0.119279724377029,0.100819669867717
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52332,0.0112303220319802,0.00664409738922652,-0.00179210885090384,0.0242527529148641,0.0909896799450096
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52332,0.0202231034946882,0.0112074906306193,-0.00174357814132551,0.042189785130702,0.0711773242862862
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52332,0.00593476089615925,0.00664619682511338,-0.00709178488106298,0.0189613066733815,0.371890058070056
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52332,0.0390913237730067,0.00937090422042673,0.0207243515009703,0.0574582960450431,3.03619311221401e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52332,0.00869971246671847,0.0114015763533347,-0.0136473771858176,0.0310468021192546,0.445454975211048
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52332,0.0434780190392005,0.00442808793899729,0.0347989666787658,0.0521570713996352,1.03620071838912e-22
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38922,0.01365135437163,0.0103012384044397,-0.00653907290107169,0.0338417816443317,0.185131016351274
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38922,0.00916284436494465,0.00883181578128939,-0.00814751456638255,0.0264732032962718,0.299537359096823
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38922,0.0328588848017638,0.0127362451259015,0.00789584435499695,0.0578219252485306,0.0098959707896905
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38922,0.00733429796702129,0.0099635972152024,-0.0121943525747754,0.026862948508818,0.461681847171925
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52326,-0.0243355871300038,0.0151878172403701,-0.0541037089211291,0.00543253466112152,0.10910079218275
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52326,-0.0142338496345754,0.0232498190973699,-0.0598034950654204,0.0313357957962697,0.540402627678289
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52326,0.0383303989753958,0.0363165567366796,-0.0328500522284962,0.109510850179288,0.29122946630023
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52326,0.0389636622969684,0.0389986284172618,-0.0374736494008647,0.115400973994802,0.317755054600583
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52326,-0.00443137489743026,0.0125536244785396,-0.0290364788753678,0.0201737290805073,0.724094914265394
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52326,0.0365128101082925,0.0174294029652144,0.00235118029647229,0.0706744399201127,0.0361909663140209
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52326,0.00901075538701048,0.00917953865806812,-0.00898114038280304,0.027002651156824,0.326300758158481
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",36050,0.0474649830752301,0.0123214272679457,0.0233149856300564,0.0716149805204038,0.000118113739023533
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",36050,0.041681661979808,0.0129121993918641,0.0163737511717543,0.0669895727878617,0.00125208922883506
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",36050,-0.00301830211679197,0.0180758161258402,-0.0384469017234388,0.0324102974898549,0.867390608217183
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",36050,0.0149111123543092,0.00753868153553381,0.000135296544662893,0.0296869281639554,0.047974664078101
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40621,-0.00729746348544147,0.00601384643535505,-0.0190846024987374,0.00448967552785442,0.224985345355274
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40621,-0.0106287294478759,0.00711224056062247,-0.0245687209466959,0.00331126205094415,0.13509147317062
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40621,0.0124321671530325,0.00588711572962904,0.000893420322959535,0.0239709139831054,0.0347288089065388
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40621,0.0274139041367068,0.0135616821118738,0.000833007197434191,0.0539948010759795,0.0432592005790689
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40621,0.0620171608244465,0.0075475580380045,0.0472239470699577,0.0768103745789353,2.31411764617805e-16
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40621,-0.00157937937735324,0.0107682255086418,-0.0226851013742911,0.0195263426195847,0.88339481206918
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52332,-0.0170869983146295,0.0124069603600144,-0.0414046406202578,0.00723064399099876,0.168460443432292
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52332,0.00603158293959902,0.00937699417738431,-0.0123473256480742,0.0244104915272723,0.520079931432317
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52332,0.0103195335286054,0.0237818880273298,-0.0362929670049611,0.0569320340621719,0.664347629473307
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52332,-0.0112334139091776,0.00875428274785017,-0.0283918080949639,0.00592498027660876,0.199438137448536
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52332,-0.00841669151283138,0.0103322472457911,-0.028667896114582,0.0118345130889193,0.41530731657217
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52332,0.0468529915095645,0.0123626029028685,0.0226222898199423,0.0710836931991868,0.000151091791863078
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52332,0.00567419540737763,0.00415090719482301,-0.00246158269447547,0.0138099735092307,0.171645739326162
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34940,0.0273794823499125,0.0108313036840941,0.00615012712908812,0.0486088375707369,0.0115042063547286
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34940,0.0536296556658415,0.0133015603724713,0.0275585973357977,0.0797007139958853,5.60599021995402e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34940,-0.0276353056168092,0.00928819274140718,-0.0458401633899672,-0.00943044784365111,0.00293905307240887
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34940,-0.00709425072761146,0.00873552564094332,-0.0242158809838604,0.0100273795286374,0.416759327857046
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52432,0.00968300703509742,0.00554647632252233,-0.00118808655704635,0.0205541006272412,0.0808599079933298
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52432,-0.00273929091611148,0.015435502057836,-0.0329928749494701,0.0275142931172471,0.859143198284109
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52432,0.0100045283693687,0.00461445307548752,0.000960200341413189,0.0190488563973243,0.0301623042255716
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52432,0.00356912216609185,0.0044424179339212,-0.0051380169843937,0.0122762613165774,0.421740919546518
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52432,0.0476006787995536,0.00755386994129883,0.0327950937146079,0.0624062638844993,3.00077868358666e-10
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52432,0.0127518583251718,0.0056647419600378,0.00164896408349769,0.0238547525668459,0.0243889824997491
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52432,-0.0012186141745275,0.00464354024422158,-0.0103199530532018,0.0078827247041468,0.792990627699645
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52432,0.0889527089075877,0.01424379497846,0.0610348707498061,0.116870547065369,4.31101096374852e-10
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45745,-0.0364299541189318,0.00476044098926682,-0.0457604184578948,-0.0270994897799689,2.07697314440305e-14
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45745,0.0211161435158445,0.00495181285099373,0.0114105903278968,0.0308216967037922,2.01618491513628e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45745,0.005482148752427,0.00524257665111617,-0.00479330148376069,0.0157575989886147,0.295716036812851
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45745,-0.0307511874792061,0.00716436692730436,-0.0447933466567227,-0.0167090283016896,1.77884587845339e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45745,-0.0101737603578366,0.00478824763093923,-0.0195587257144774,-0.000788795001195674,0.0336234551321646
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52200,-0.00141545910003718,0.00486332596105877,-0.0109475779837124,0.00811665978363801,0.771017577828484
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52200,-0.0184178779283222,0.00394533559940152,-0.0261507357031491,-0.0106850201534952,3.05464601506453e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52200,-0.00109770219454715,0.00408523539399789,-0.00910476356678302,0.00690935917768872,0.788163065851007
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52200,-0.0369580968929297,0.00885934133741378,-0.0543224059142607,-0.0195937878715987,3.03506877227253e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52219,-0.0320896067667122,0.00438799572067949,-0.040690078379244,-0.0234891351541804,2.69691709620108e-13
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52219,-0.0527447940610916,0.00867273483355914,-0.0697433543348675,-0.0357462337873157,1.20803738545425e-09
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52332,-0.0260713941403291,0.0040065840624945,-0.0339242989028184,-0.0182184893778399,7.81633599232907e-11
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52332,-0.0303141267603313,0.00459156595856294,-0.0393135960391146,-0.0213146574815479,4.14065871955284e-11
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52332,-0.00178603256314171,0.0069688009976002,-0.0154448825184381,0.0118728173921547,0.797729356845981
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52332,-0.0291311835624371,0.00960388819362652,-0.0479548044219451,-0.0103075627029291,0.00242187353895017
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52332,0.0185084035902057,0.0121364049079629,-0.00527895002940161,0.042295757209813,0.127264830315965
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52332,-0.0436809076164133,0.0115016507080039,-0.066224143004101,-0.0211376722287255,0.000146362151962997
PLA2G15,Phospholipase A2 group XV,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42326,-0.0119853705438128,0.00264545794151436,-0.0171704681091809,-0.00680027297844466,5.9350060819988e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X864.Number of days or week walked 10+ minutes,51840,-0.159812784504349,0.0419220766018858,-0.241980054644045,-0.0776455143646526,0.000138134207712481
PLA2G15,Phospholipase A2 group XV,Physical activities,X874.Duration of walks,48726,-0.0107319186189432,0.00218163937361674,-0.015007931791232,-0.00645590544665437,8.76055989254135e-07
PLA2G15,Phospholipase A2 group XV,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50893,-0.270561487693532,0.0404819800771644,-0.349906168644775,-0.19121680674229,2.38957633811666e-11
PLA2G15,Phospholipase A2 group XV,Physical activities,X894.Duration of moderate activity,46010,-0.114123074839481,0.0501252467017069,-0.212368558374827,-0.0158775913041356,0.0228131663446014
PLA2G15,Phospholipase A2 group XV,Physical activities,X90087.No-wear time bias adjusted average acceleration,33503,-0.0100386907512712,0.00487665050729686,-0.019596925745573,-0.000480455756969341,0.0396000737302297
PLA2G15,Phospholipase A2 group XV,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50795,-0.33872809443856,0.0421713607762974,-0.421383961560103,-0.256072227317017,1.00619517643952e-15
PLA2G15,Phospholipase A2 group XV,Physical activities,X914.Duration of vigorous activity,40452,-0.0050712175502936,0.00266010701784207,-0.010285027305264,0.000142592204676854,0.0566242745737943
